<SEC-DOCUMENT>0000708781-23-000017.txt : 20230421
<SEC-HEADER>0000708781-23-000017.hdr.sgml : 20230421
<ACCEPTANCE-DATETIME>20230421143446
ACCESSION NUMBER:		0000708781-23-000017
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230418
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230421
DATE AS OF CHANGE:		20230421

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CASS INFORMATION SYSTEMS INC
		CENTRAL INDEX KEY:			0000708781
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-BUSINESS SERVICES, NEC [7389]
		IRS NUMBER:				431265338
		STATE OF INCORPORATION:			MO
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-20827
		FILM NUMBER:		23835965

	BUSINESS ADDRESS:	
		STREET 1:		12444 POWERSCOURT DRIVE
		CITY:			ST. LOUIS
		STATE:			MO
		ZIP:			63131
		BUSINESS PHONE:		314-506-5500

	MAIL ADDRESS:	
		STREET 1:		12444 POWERSCOURT DRIVE
		CITY:			ST. LOUIS
		STATE:			MO
		ZIP:			63131

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CASS COMMERCIAL CORP
		DATE OF NAME CHANGE:	19950518
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cass-20230418.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:0ddd94d8-9c78-4f2d-9ad0-68381cce4597,g:adb5d3f7-7c58-4aa6-b481-5b41f111169d,d:8c472aafa4754eda92600c34ccf5316b--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cass-20230418</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl80L2ZyYWc6NjRmNDEzZWQ3ZTdjNDY4ZGJhNTM5Y2EwOGYwNmJhMjkvdGFibGU6NjM5OGVhMzU4MDgzNDQwMmE5OWJhOWViNDMxNTFmMzcvdGFibGVyYW5nZTo2Mzk4ZWEzNTgwODM0NDAyYTk5YmE5ZWI0MzE1MWYzN18xLTEtMS0xLTQ5NDQw_f884b5f1-15a0-4826-8568-963e0267cfe1">0000708781</ix:nonNumeric><ix:nonNumeric contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl80L2ZyYWc6NjRmNDEzZWQ3ZTdjNDY4ZGJhNTM5Y2EwOGYwNmJhMjkvdGFibGU6NjM5OGVhMzU4MDgzNDQwMmE5OWJhOWViNDMxNTFmMzcvdGFibGVyYW5nZTo2Mzk4ZWEzNTgwODM0NDAyYTk5YmE5ZWI0MzE1MWYzN18yLTEtMS0xLTQ5NDQw_40e45d8d-feb0-4b4f-a7b9-45559235c79a">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cass-20230418.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000708781</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-18</xbrli:startDate><xbrli:endDate>2023-04-18</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i8c472aafa4754eda92600c34ccf5316b_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGV4dHJlZ2lvbjo0NTQ4ZDI1MTQyY2U0NTI3OTYxNGMyZTg3NjkzZTQ4MV8xMjY2_61fb654d-816c-4c7d-bc75-eb8fce248a7e">8-K</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 13 OR 15(d)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report (date of earliest event reported):&#160;<ix:nonNumeric contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGV4dHJlZ2lvbjo0NTQ4ZDI1MTQyY2U0NTI3OTYxNGMyZTg3NjkzZTQ4MV8xMjY3_02c5647d-36a0-425a-b4b9-33c0445c8925">April 18, 2023</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGV4dHJlZ2lvbjo0NTQ4ZDI1MTQyY2U0NTI3OTYxNGMyZTg3NjkzZTQ4MV8xMjY4_62afc22e-ce72-467d-b7c9-76ba3c764854">CASS INFORMATION SYSTEMS, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGFibGU6NzcwYTU1YTJkNWZlNDhkMGI3ODkzZDY4MGZkMTkxMjgvdGFibGVyYW5nZTo3NzBhNTVhMmQ1ZmU0OGQwYjc4OTNkNjgwZmQxOTEyOF8wLTAtMS0xLTQ5NDQw_f8733ec8-4468-459a-85ab-17fea517e00a">Missouri</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGFibGU6NzcwYTU1YTJkNWZlNDhkMGI3ODkzZDY4MGZkMTkxMjgvdGFibGVyYW5nZTo3NzBhNTVhMmQ1ZmU0OGQwYjc4OTNkNjgwZmQxOTEyOF8wLTEtMS0xLTQ5NDQw_40412d78-65f2-4a71-bbc2-b9714760890b">000-20827</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGFibGU6NzcwYTU1YTJkNWZlNDhkMGI3ODkzZDY4MGZkMTkxMjgvdGFibGVyYW5nZTo3NzBhNTVhMmQ1ZmU0OGQwYjc4OTNkNjgwZmQxOTEyOF8wLTItMS0xLTQ5NDQw_3046d623-e747-4184-a608-f569f6a8dc85">43-1265338</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Commission<br/>File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:-1.31pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGFibGU6ZjQwMzVkMWVkMmE2NDRjOTg0OWJiYTZjMDQxMDZmMjYvdGFibGVyYW5nZTpmNDAzNWQxZWQyYTY0NGM5ODQ5YmJhNmMwNDEwNmYyNl8wLTAtMS0xLTQ5NDQwL3RleHRyZWdpb246MTkwNTRmYjUyZjg4NGE2ZmE1ODRhZDc0MTQ2YThmZjlfNA_0b152b85-639c-4950-9d51-84e91b2351e2">12444 Powerscourt Drive</ix:nonNumeric>,&#160;<ix:nonNumeric contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGFibGU6ZjQwMzVkMWVkMmE2NDRjOTg0OWJiYTZjMDQxMDZmMjYvdGFibGVyYW5nZTpmNDAzNWQxZWQyYTY0NGM5ODQ5YmJhNmMwNDEwNmYyNl8wLTAtMS0xLTQ5NDQwL3RleHRyZWdpb246MTkwNTRmYjUyZjg4NGE2ZmE1ODRhZDc0MTQ2YThmZjlfOA_fd108b36-6aa5-4ce2-bccc-c27dc41e0999">Suite 550</ix:nonNumeric></span></div><div style="padding-right:-1.31pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGFibGU6ZjQwMzVkMWVkMmE2NDRjOTg0OWJiYTZjMDQxMDZmMjYvdGFibGVyYW5nZTpmNDAzNWQxZWQyYTY0NGM5ODQ5YmJhNmMwNDEwNmYyNl8wLTAtMS0xLTQ5NDQwL3RleHRyZWdpb246MTkwNTRmYjUyZjg4NGE2ZmE1ODRhZDc0MTQ2YThmZjlfMTE_03d785a6-0c4f-4ac9-b7f8-dfbee96f4910">St. Louis</ix:nonNumeric>,&#160;<ix:nonNumeric contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGFibGU6ZjQwMzVkMWVkMmE2NDRjOTg0OWJiYTZjMDQxMDZmMjYvdGFibGVyYW5nZTpmNDAzNWQxZWQyYTY0NGM5ODQ5YmJhNmMwNDEwNmYyNl8wLTAtMS0xLTQ5NDQwL3RleHRyZWdpb246MTkwNTRmYjUyZjg4NGE2ZmE1ODRhZDc0MTQ2YThmZjlfMTU_386c5169-e3de-4797-b33d-3fd6e06d8880">Missouri</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGFibGU6ZjQwMzVkMWVkMmE2NDRjOTg0OWJiYTZjMDQxMDZmMjYvdGFibGVyYW5nZTpmNDAzNWQxZWQyYTY0NGM5ODQ5YmJhNmMwNDEwNmYyNl8wLTEtMS0xLTQ5NDQw_e5a7ff6f-cc24-40f1-be39-af7db4e619b3">63131</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGV4dHJlZ2lvbjo0NTQ4ZDI1MTQyY2U0NTI3OTYxNGMyZTg3NjkzZTQ4MV8xMjY5_077762aa-7fdb-4c92-8280-55c947655c72">314</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGV4dHJlZ2lvbjo0NTQ4ZDI1MTQyY2U0NTI3OTYxNGMyZTg3NjkzZTQ4MV8xMjcw_828c166b-33ef-4cbc-a4ce-39272cf8b24b">506-5500</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">______________________</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form&#160;8-K&#160;filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.658%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418" name="dei:WrittenCommunications" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGFibGU6Mjg0YWMxMjAzM2JiNDY2YTk2YmI3NzZhMjJlYWY3MjQvdGFibGVyYW5nZToyODRhYzEyMDMzYmI0NjZhOTZiYjc3NmEyMmVhZjcyNF8wLTAtMS0xLTQ5NDQw_9ef52026-843b-4665-84c5-31093d267fdf">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act.</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGFibGU6Mjg0YWMxMjAzM2JiNDY2YTk2YmI3NzZhMjJlYWY3MjQvdGFibGVyYW5nZToyODRhYzEyMDMzYmI0NjZhOTZiYjc3NmEyMmVhZjcyNF8yLTAtMS0xLTQ5NDQw_4a4203b5-a806-4882-ba5e-a33d6f236630">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule&#160;14a-12&#160;under the Exchange Act.</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGFibGU6Mjg0YWMxMjAzM2JiNDY2YTk2YmI3NzZhMjJlYWY3MjQvdGFibGVyYW5nZToyODRhYzEyMDMzYmI0NjZhOTZiYjc3NmEyMmVhZjcyNF80LTAtMS0xLTQ5NDQw_5e669f6b-a4e2-4739-8cb9-f5b515162442">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement&#160;communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act.</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGFibGU6Mjg0YWMxMjAzM2JiNDY2YTk2YmI3NzZhMjJlYWY3MjQvdGFibGVyYW5nZToyODRhYzEyMDMzYmI0NjZhOTZiYjc3NmEyMmVhZjcyNF82LTAtMS0xLTQ5NDQw_875cdc2e-009b-4c75-869d-ffb88ffcca4d">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt 2px 28pt;text-align:left;text-indent:-27pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement&#160;communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act.</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.778%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading<br/>Symbol</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange<br/>on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGFibGU6MTUzNmE5NTg5OGU3NDM3NmFlNDdmYTcyNTIyNzM5MjYvdGFibGVyYW5nZToxNTM2YTk1ODk4ZTc0Mzc2YWU0N2ZhNzI1MjI3MzkyNl8xLTAtMS0xLTQ5NDQw_1acf3274-4e6e-46c9-8bb6-8c356edc44f3">Common Stock, par value $0.50 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGFibGU6MTUzNmE5NTg5OGU3NDM3NmFlNDdmYTcyNTIyNzM5MjYvdGFibGVyYW5nZToxNTM2YTk1ODk4ZTc0Mzc2YWU0N2ZhNzI1MjI3MzkyNl8xLTItMS0xLTQ5NDQw_31b4d533-cbc5-4246-bedf-323650142360">CASS</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGFibGU6MTUzNmE5NTg5OGU3NDM3NmFlNDdmYTcyNTIyNzM5MjYvdGFibGVyYW5nZToxNTM2YTk1ODk4ZTc0Mzc2YWU0N2ZhNzI1MjI3MzkyNl8xLTQtMS0xLTQ5NDQw_50d5d141-bcb0-4990-9a59-86bcf2660e81">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule&#160;12b-2&#160;of the Securities Exchange Act of 1934&#160;(&#167;240.12b-2&#160;of this chapter).</span></div><div style="margin-top:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGV4dHJlZ2lvbjo0NTQ4ZDI1MTQyY2U0NTI3OTYxNGMyZTg3NjkzZTQ4MV8xMjcx_2e7ddc56-aac5-4502-b397-dde1857c7342">&#9744;</ix:nonNumeric></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i8c472aafa4754eda92600c34ccf5316b_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;5.02.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Approval of the 2023 Omnibus Stock and Performance Compensation Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the 2023 Annual Meeting of Shareholders (the &#8220;Annual Meeting&#8221;) of Cass Information Systems, Inc. (the &#8220;Company&#8221;), held on April 18, 2023 (the &#8220;Annual Meeting&#8221;), the Company&#8217;s shareholders approved the Cass Information Systems, Inc. 2023 Omnibus Stock and Performance Compensation Plan (the &#8220;2023 Omnibus Plan&#8221;). The 2023 Omnibus Plan was previously approved by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;) on February 16, 2023, upon recommendation of the Compensation Committee of the Board, subject to shareholder approval. The 2023 Omnibus Plan has been established to replace, on a prospective basis, the Cass Information Systems, Inc. Amended and Restated Omnibus Stock and Performance Compensation Plan, which was previously approved by shareholders and terminated in accordance with its terms on April 17, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2023 Omnibus Plan permits the grant of stock options (incentive stock options and nonqualified stock options), stock appreciation rights, restricted stock, restricted stock units, phantom stock, and cash-based performance awards. The 2023 Omnibus Plan will be administered by the Compensation Committee of the Board or by its delegate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A total of 1,000,000 shares of Common Stock, $0.50 per share, is available for grants under the 2023 Omnibus Plan to eligible employees and non-employee directors. The number of shares available for grant is subject to adjustment under certain circumstances described in the 2023 Omnibus Plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board may terminate or amend the 2023 Omnibus Plan at any time; provided, however, that amendment of the 2023 Omnibus Plan will be subject to shareholder approval in certain circumstances. The 2023 Omnibus Plan will terminate on April 17, 2033. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This description of the 2023 Omnibus Plan is a summary only and is qualified by reference to the 2023 Omnibus Plan, which is filed as Exhibit 10.1 hereto. A more complete description of the terms of the 2023 Omnibus Plan can be found in section IV, &#8220;Approval of the 2023 Omnibus Stock and Performance Compensation Plan &#8211; Proposal 4&#8221; on pages 17 to 25 of the Company&#8217;s definitive proxy statement filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on March 8, 2023, which description is incorporated by reference herein</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Grant of Restricted Stock</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously announced by the Company, Martin H. Resch was appointed as the Company&#8217;s Chief Executive Officer effective April 18, 2023 as part of the Company&#8217;s succession planning. On April 20, 2023, the Board, upon the recommendation of the Compensation Committee, granted Mr. Resch 5,318 shares of restricted stock under the 2023 Omnibus Plan in connection with his transition to Chief Executive Officer. Mr. Resch&#8217;s restricted stock grant was made in accordance with the terms of the Company&#8217;s long-term incentive compensation program for executive officers and is in addition to the compensation package previously approved for Mr. Resch as described in the Company&#8217;s Current Report on Form 8-K filed with the SEC on February 22, 2023. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                The terms of the restricted stock are as set forth in the relevant portions of the Company&#8217;s form of Restricted Stock Agreement (the &#8220;Award Agreement&#8221;). Of the total shares awarded, 2,127 are time-based restricted stock that will cliff vest three years from the date of grant and 3,191 are performance-based restricted stock that will vest three years from the date of grant with amounts earned, if any, based on the Company&#8217;s achievement of earnings per share and return on equity performance targets for the prospective three-year performance period. The ultimate number of performance-based shares earned will range from 0% to 150% of the target award based on the Company&#8217;s achievement of these performance goals, with no performance-based awards being earned if threshold performance targets are not met. Vesting is accelerated, in certain circumstances, upon termination of employment in the event of death, disability or following a change of control, subject to the terms set forth in the Award Agreement. Time-based restricted stock carries voting and dividend rights from the date of grant; holders of performance-based restricted stock are entitled to voting and dividend rights only upon satisfaction of applicable performance criteria and vesting of the shares. In both cases, the payment of any dividends is deferred until the shares to which such dividends are attributable vest. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that the Company materially restates its financial statements, the restricted stock shall be subject to rescission, revocation, adjustment, modification or otherwise in accordance with the Company&#8217;s governing Clawback </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Policy, as it may be amended from time to time in compliance with the rules and regulations of the SEC and the Nasdaq Stock Market. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The summary of the terms of the restricted stock is qualified in its entirety by reference to the terms set forth in the form of the Award Agreement, a copy of which is filed as Exhibit 10.2 to this Current Report on Form 8-K and incorporated herein by reference. Further information about the Company&#8217;s long-term incentive compensation program is discussed in the Company&#8217;s most recent definitive proxy statement on Schedule 14A, filed with the SEC on March 8, 2023.</span></div><div id="i8c472aafa4754eda92600c34ccf5316b_99"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;5.07.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Submission of Matters to a Vote of Security Holders.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 18, 2023, the Company held the Annual Meeting.  The following is a summary of the matters voted on at the Annual Meeting:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Election of five directors to serve three-year terms ending in 2026, as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.030%"><tr><td style="width:1.0%"></td><td style="width:26.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.972%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.972%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.972%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.974%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Nominee</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Votes For</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Votes Against</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Abstentions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Broker Non-Votes</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eric H. Brunngraber</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,544,237</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591,965</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,000</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,878,709</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benjamin F. Edwards, IV</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,788,369</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345,889</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,944</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,878,709</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ann W. Marr</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,996,878</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,273</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,052</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,878,709</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Martin H. Resch</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,948,866</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,571</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,765</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,878,709</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Joseph D. Rupp</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,978,646</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,925</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,632</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,878,709</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All director nominees were elected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Advisory approval of the Company&#8217;s executive compensation:</span></div><div style="padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.636%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Votes For</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Votes Against</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Abstentions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Broker Non-Votes</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,900,410</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,377</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,415</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,878,709</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s executive compensation was approved by advisory vote.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Advisory vote on the frequency of executive compensation advisory vote:</span></div><div style="padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.545%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">1 Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2 Years</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">3 Years</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Abstentions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Broker Non-Votes</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,322,698</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,015</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787,427</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,062</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,878,709</span></td></tr></table></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By advisory vote, the shareholders voted to hold an advisory vote on executive compensation every year.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Approval of the Company&#8217;s 2023 Omnibus Plan:</span></div><div style="padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.636%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Votes For</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Votes Against</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Abstentions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Broker Non-Votes</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,788,611</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318,396</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,195</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,878,709</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s 2023 Omnibus Plan was approved.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) Ratification of the selection of KPMG LLP as the Company&#8217;s independent registered public accounting firm </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for 2023:</span></div><div style="padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:47.727%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Votes For</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Votes Against</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Abstentions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,930,125</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,424</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,362</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The selection of KPMG LLP to serve as the Company&#8217;s independent registered public accounting firm for 2023 was ratified.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i8c472aafa4754eda92600c34ccf5316b_10"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;8.01.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Events.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also on April 18, 2023, the Company&#8217;s Board of Directors declared a second quarter dividend of $0.29 per share payable on June 15, 2023 to shareholders of record on June 5, 2023. </span></div><div id="i8c472aafa4754eda92600c34ccf5316b_13"></div><div style="-sec-extract:summary;margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;9.01.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Statements and Exhibits.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exhibits.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.173%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit&#160;Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description of Exhibit</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit101-2023omnibusplan.htm">Cass Information Systems, Inc. 2023 Omnibus Stock and Performance Compensation Plan</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit102-restrictedstock.htm">Form of Restricted Stock Award Agreement under the Cass Information Systems, Inc. 2023 Omnibus Stock and Performance Compensation Plan</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i8c472aafa4754eda92600c34ccf5316b_16"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated: April 21, 2023</span></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.809%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.476%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CASS INFORMATION SYSTEMS, INC.</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Martin H. Resch</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Martin H. Resch</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Michael J. Normile</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. Normile</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>exhibit101-2023omnibusplan.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ib19f40db023c44e3a7a3a756189bea3a_33"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.1</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">CASS INFORMATION SYSTEMS, INC.</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">2023 OMNIBUS STOCK AND PERFORMANCE COMPENSATION PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">ARTICLE I</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">PURPOSE</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The purpose of the Cass Information Systems, Inc. 2023 Omnibus Stock and Performance Compensation Plan (the &#8220;Plan&#8221;) is to provide stock compensation and other incentive opportunities for Non-Employee Directors and key Employees to align their personal financial interest with the Company&#8217;s stockholders. The Plan includes provisions for stock options, stock appreciation rights, restricted stock, restricted stock units, phantom stock and performance related awards.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">ARTICLE II</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">DEFINITIONS</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.1 &#8220;BOARD&#8221; OR &#8220;BOARD OF DIRECTORS&#8221; means the Board of Directors of the Company.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.2 &#8220;CHANGE OF CONTROL&#8221; means one or more of the following occurrences&#58;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(a) Any individual, corporation (other than the Company), partnership, trust, association, pool, syndicate, or any other entity or any group of persons acting in concert, becomes a beneficial owner (within the meaning of Rule 13d-3 under the Securities Exchange Act of 1934) of securities of the Company possessing more than one-third (1&#47;3) of the voting power for the election of the Board of Directors&#59;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(b) The consummation of any consolidation, merger, or other business combination involving the Company in which holders of voting securities of the Company, immediately prior to such consummation, own, as a group, immediately after such consummation, voting securities of the Company (or, if the Company does not survive such transaction, voting securities of the entity surviving such transaction) having less than two-thirds (2&#47;3) of the total voting power in an election of the directors of the Company or such other surviving entity&#59;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(c) During any period of two (2) consecutive years, individuals, who at the beginning of such period, constitute members of the Board of Directors cease for any reason to constitute at least a majority thereof, unless the election, or the nomination for election by the Company&#8217;s stockholders, of each new director of the Company is approved by a vote of at least two-thirds (2&#47;3) of the members of the Board of Directors then still in office who are directors of the Company at the beginning of any such period&#59; or</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(d) The consummation of any sale, lease, exchange, or other transfer (in one transaction or in a series of related transactions) of all, or substantially all, of the assets of the Company (on a consolidated basis) to a party which is not controlled by or under common control with the Company.</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">In the event that any provision of this definition of Change of Control provides for a smaller degree of change of ownership than that required in the corresponding meaning of change in the ownership or effective control of the Company, or a change in the ownership of a substantial </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">portion of the assets of the Company under Treasury Regulation Section 1.409A-3(i)(5) or any successor regulation and the benefit which becomes vested or payable on account of a Change of Control is subject to Section 409A of the Code, the determination as to whether there has been a Change of Control shall be determined by the provisions of such Treasury Regulation Section 1.409A-3(i)(5) or any successor regulation.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.3 &#8220;CODE&#8221; means the Internal Revenue Code of 1986, as amended from time to time.  Any reference to a section of the Code shall be deemed to include a reference to any regulations promulgated thereunder.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.4 &#8220;COMPANY&#8221; or &#8220;CASS&#8221; means Cass Information Systems, Inc., a Missouri corporation, and any successor corporation by merger or otherwise. When the context so admits or requires, &#8220;Company&#8221; or &#8220;Cass&#8221; includes Subsidiaries.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.5 &#8220;COMMITTEE&#8221; means a committee of two (2) or more members of the Board appointed by the Board of Directors to administer the Plan pursuant to Article III herein. A person may serve on the Committee only if he or she is a &#8220;non-employee director&#8221; for purposes of Rule 16b-3 under the Securities Exchange Act of 1934, as amended.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.6 &#8220;EMPLOYEE&#8221; means any person employed by the Company or a Subsidiary on a full-time salaried basis. The term &#8220;Employee&#8221; shall not include a person hired as an independent contractor, leased employee, consultant or a person otherwise designated by the Committee at the time of hire as not eligible to participate in the Plan.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.7 &#8220;FAIR MARKET VALUE&#8221; means, with respect to any Stock and awards made pursuant to this Plan, the closing price of a share of Stock on the date as of which the determination is being made, or as otherwise determined in a manner specified by the Committee.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.8 &#8220;INCENTIVE STOCK OPTION&#8221; or &#8220;ISO&#8221; means an Option grant which meets or complies with the terms and conditions set forth in the Section 422 of the Code and applicable regulations.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.9 &#8220;INDICATORS OF PERFORMANCE&#8221; means the criteria used by the Committee to evaluate the Company&#8217;s performance with respect to awards under the Plan including&#58; the Company&#8217;s Pretax Income&#59; Net Income&#59; Net Earnings, Earnings Per Share&#59; Revenue&#59; Gross Profit, Fee Revenue&#59; Expenses&#59; Return on Assets&#59; Return on Equity&#59; Return on Average Equity&#59; Return on Investment&#59; Return on Capital and Revenue&#59; Net Profit Margin&#59; Operating Profit Margin&#59; Gross Margin, Discretionary Cash Flow (net cash provided by operating activities, less estimated total changes in operating assets and liabilities)&#59; Total Stockholder Return&#59; Earnings before Interest and Taxes&#59; Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)&#59; Interest Income&#59; Net Interest Income&#59; Capitalization&#59; Capital-to-Asset Ratio&#59; Liquidity&#59; Reserve Adds or Replacement&#59; Funding and Development Costs&#59; Production Volumes&#59; Stock Price&#59; Economic Value Added&#59; Working Capital&#59; Market Share&#59; Results of Customer Satisfaction Surveys and other measures of Quality, Safety, Productivity, Cost Management or Process Improvement or other measures the Committee approves. The Committee has the discretion to select the particular Indicators of Performance to be utilized in determining awards, and such Indicators of Performance may vary between Performance Periods and different awards. In addition, such Indicators of Performance may be determined solely by reference to the performance of the Company, a Subsidiary, or a division or unit of any of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">foregoing or based upon comparisons of any of the performance measures relative to other companies. In establishing an Indicator of Performance, the Committee may exclude the impact of any event or occurrence which the Committee determines should appropriately be excluded such as, for example, a restructuring or other nonrecurring charge, an event either not directly related to the operations of the Company or not within the reasonable control of the Company&#8217;s management, or a change in accounting standards required by U.S. generally accepted accounting principles.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.10 &#8220;NON-EMPLOYEE DIRECTOR&#8221; means any person duly elected a director of the Company who is not an Employee of the Company.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.11 &#8220;OPTION&#8221; or &#8220;STOCK OPTION&#8221; means a right granted under the Plan to a Participant to purchase a stated number of shares of Stock at a stated exercise price.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.12 &#8220;PARTICIPANT&#8221; means an Employee or Non-Employee Director who has received or been granted a benefit under the Plan.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.13 &#8220;PERFORMANCE AWARD&#8221; means an award established by the Committee pursuant to Article XI.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.14 &#8220;PERFORMANCE AWARD PARTICIPANT&#8221; means any eligible Employee so designated by the Committee.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.15 &#8220;PERFORMANCE PERIOD&#8221; means a period established by the Committee of not less than one (1) year, at the conclusion of which, the Performance Award, subject to the terms of the Performance Award Agreement, becomes vested and non-forfeitable or settlement is made with a Performance Award Participant with respect to the Performance Award.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.16 &#8220;PHANTOM STOCK&#8221; means the right to receive, in cash or Stock equivalent, an amount equal to the Fair Market Value of a share of Stock for each unit of Phantom Stock.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.17 &#8220;RESTRICTED STOCK&#8221; means Stock granted pursuant to Article VIII of the Plan.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.18 &#8220;RESTRICTED STOCK UNIT&#8221; or &#8220;RSU&#8221; means Restricted Stock Unit granted pursuant to Article IX of the Plan. RSU&#8217;s are similar to Restricted Stock except that no shares of stock are actually issued to a Participant. Instead, a Participant is granted units and each unit has a Fair Market Value equal to the Fair Market Value of a share of Stock as of any given date.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.19 &#8220;RESTRICTION PERIOD&#8221; is the period of time during which shares of Restricted Stock, RSUs or Phantom Stock are subject to forfeiture if the restrictions applicable to such shares or RSUs are violated, as determined by the Committee.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.20 &#8220;SHARE RESERVE&#8221; means the number of shares of Stock reserved for issuance under Article V of this Plan.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.21 &#8220;SPECIFIED EMPLOYEE&#8221; means a specified employee as defined in Section 409A(a)(2)(B) of the Code.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.22 &#8220;SPREAD&#8221; means, with respect to an Option or SAR, the difference of the Fair Market Value of a share of Stock on the exercise date and the Fair Market Value of a share of Stock on the grant date.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.23 &#8220;STOCK&#8221; means the common stock of the Company.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.24 &#8220;STOCK APPRECIATION RIGHT&#8221; or &#8220;SAR&#8221; means a right to receive a payment equal to the excess of the Fair Market Value of Stock as of the exercise date over the exercise price specified in the SAR.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.25 &#8220;SUBSIDIARY&#8221; means any corporation or similar legal entity (other than the Company) in which the Company or a Subsidiary of the Company owns fifty percent (50%) or more of the total combined voting power of all classes of stock, provided that, with regard to ISOs, &#8220;Subsidiary&#8221; shall have the meaning provided under Section 424(f) of the Code.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.26 &#8220;TEN PERCENT STOCKHOLDER&#8221; means a person who owns (or is deemed to own pursuant to Section 424(d) of the Code) Stock possessing more than ten percent (10%) of the total combined voting power of all classes of Stock of the Company or any of its affiliates.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.27 &#8220;TERMINATED FOR CAUSE&#8221; and &#8220;TERMINATION FOR CAUSE&#8221; means termination by the Company of the Participant&#8217;s employment or service by reason of&#58; (a) an order of any federal or state regulatory authority having jurisdiction over the Company or any Subsidiary&#59; (b) the willful failure of the Participant substantially to perform his or her duties set forth by his or her employment agreement (other than any such failure due to the Participant&#8217;s physical or mental illness)&#59; (c) a willful breach by the Participant of any material provision of any written agreement with the Company or any Subsidiary&#59; (d) the Participant&#8217;s commission of a crime that constitutes a felony or other crime of moral turpitude or criminal fraud&#59; (e) any act of disloyalty or breach of responsibilities to the Company or any Subsidiary, which is intended by the Participant to cause material harm to the Company&#59; (f) misappropriation (or attempted misappropriation) of any of the Company&#8217;s or any Subsidiary&#8217;s funds or property by the Participant&#59; or (g) the Participant&#8217;s material and intentional violation of any Company or Subsidiary policy applicable to the Participant.  Notwithstanding the preceding, in the event the Participant is subject to a employment agreement or other agreement which provides for a definition of Cause, the definition in such agreement shall control.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.28 &#8220;TOTAL DISABILITY&#8221; and &#8220;TOTALLY DISABLED&#8221; means that the Participant is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment within the meaning of Section 409A(a)(2)(C).  Notwithstanding the preceding, for purposes of an ISO granted pursuant to Article VI, the determination of Total Disability or Totally Disabled shall be made consistent with Section 22(e)(3) of the Code. All determinations shall be made by the Committee in its absolute discretion and in good faith, upon receipt of and reliance on sufficient competent medical advice.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">ARTICLE III</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">ADMINISTRATION</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">3.1 THE COMMITTEE. The Plan shall be administered by the Committee. Subject to such approvals and other authority as the Board may reserve to itself from time to time, the Committee shall, consistent with the provisions of the Plan, from time to time establish such rules and regulations and appoint such agents as it deems appropriate for the proper administration of the Plan, and make such determinations under, and such interpretations of, and take such steps in connection with the Plan, Options, SARs, Restricted Stock, RSUs, Phantom Stock or Performance Awards as it deems necessary or advisable.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">3.2 AUTHORITY OF THE COMMITTEE. Subject to the provisions herein, the Committee shall have the full power to determine the size and types of grants of Options, SARs, Restricted </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Stock, RSUs, Phantom Stock and Performance Awards&#59; to determine the terms and conditions of such grants and Performance Awards in a manner consistent with the Plan&#59; to construe and interpret the Plan and any agreement or instrument entered into under the Plan&#59; to establish, amend or waive rules and regulations for the Plan&#8217;s administration&#59; and to amend the terms and conditions of any outstanding Options, SARs, Restricted Stock, RSUs, Phantom Stock or Performance Awards to the extent such terms and conditions are within the sole discretion of the Committee as provided in the Plan and subject to the limitations and restrictions otherwise applicable under the Plan including those contained in Article XIV. The Committee may not, however, reduce the exercise price of an Option or SAR below the amounts specified in Sections 6.2 and 7.2, respectively, and the settlement value of an RSU or award of Phantom Stock below the amount specified in Sections 9.1 and 10.1, respectively, except that such amounts are subject to adjustment under Article XII. Further, the Committee shall make all other determinations which may be necessary or advisable for the administration of the Plan. As permitted by law, the Committee may delegate its authority hereunder. The Committee may take any action consistent with the terms of the Plan which the Committee deems necessary to comply with any government laws or regulatory requirements of a foreign country, including, but not limited to, modifying the terms and conditions governing any Options, SARs, Restricted Stock, RSUs, Phantom Stock or Performance Awards, or establishing any local country plans as sub-plans to this Plan.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">3.3 DECISIONS BINDING. All determinations and decisions of the Committee as to any disputed question arising under the Plan, including questions of construction and interpretation, shall be final, binding and conclusive upon all parties.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">3.4 COMMITTEE AWARDS. Award to non-employee directors of the Company who are Committee members shall be made by the Board of Directors except that a Committee member shall not participate in any Board determinations relating to grants of awards to such Committee member.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">ARTICLE IV</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">ELIGIBILITY</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Those Employees who, in the judgment of the Committee, may make key contributions to the profitability and growth of the Company shall be eligible to receive Options, SARs, Restricted Stock, RSUs, Phantom Stock and Performance Awards under the Plan. All Non-Employee Directors shall be eligible to receive Options (other than ISOs), SARs, Restricted Stock, RSUs and Phantom Stock under the Plan.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">ARTICLE V</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">MAXIMUM SHARES AVAILABLE</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5.1 SHARE RESERVE. The Stock to be distributed under the Plan may be either authorized and issued shares or unissued shares of the Stock, including but not limited to such shares held as treasury shares. Subject to adjustment under Article XII, the maximum amount of Stock which may be issued under the Plan in satisfaction of exercised awards or issued as Restricted Stock shall not exceed, in the aggregate, one million (1,000,000) shares. The maximum number of shares of Stock with respect to which Incentive Stock Options may be granted under the Plan shall be an aggregate of one million (1,000,000) shares.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5.2 INDIVIDUAL LIMITS. Subject to adjustment under Article XII, no Employee or Non-Employee Director shall be awarded, under the Plan during its term, Options, SARs, RSUs, Phantom Stock and Restricted Stock covering more than one hundred thousand (100,000) shares of Stock on an annual basis and no Non-Employee Director shall receive awards under the Plan, taken together with any cash fees paid, during any calendar year for services rendered in excess of five hundred thousand dollars ($500,000) in total value. For purposes of this Section 5.2, a grant of one SAR, RSU or share of Phantom Stock shall be treated as a grant of one share of Stock.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5.3 SHARE COUNTING.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(a) Awards of Options, SARs, Restricted Stock, RSUs and Phantom Stock shall count against the number of shares of Stock remaining available for issuance pursuant to awards granted under the Plan as one (1) share of Stock for each share of Stock covered by such awards.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(b) For awards with a variable number of shares of Stock on the grant date, the number of shares of Stock to be counted against the Share Reserve prior to the settlement of the award shall be the maximum number of shares of Stock that could be received under that particular award.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(b) Notwithstanding anything to the contrary herein, the following shares of Stock shall not be added to the Share Reserve&#58; (i) shares of Stock tendered by the Participant in payment of the exercise price of an Option&#59; (ii) shares of Stock tendered by the Participant or withheld by the Company to satisfy any tax withholding obligation with respect to an award&#59; (iii) shares of Stock subject to an award that are not issued in connection with its share settlement on exercise or vesting thereof&#59; and (iv) shares of Stock reacquired by the Company on the open market or otherwise using cash proceeds from the exercise of Options.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5.4 MINIMUM VESTING STANDARDS.  Any award granted under the Plan shall be subject to a minimum vesting or exercise period of at least one (1) year. Notwithstanding the immediately preceding sentence, the Committee may grant awards covering up to five percent (5%) of the Share Reserve without respect to the minimum vesting standards set forth in this Section 5.4.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">ARTICLE VI</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">STOCK OPTIONS</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">6.1 GRANT OF OPTIONS.</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(a) The Committee may, at any time and from time to time on or after the effective date of the Plan, grant Options under the Plan to eligible Participants, for such numbers of shares of Stock and having such terms as the Committee shall designate, subject however, to the provisions of the Plan. The Committee may also determine the type of Option granted (e.g., ISO, nonstatutory, other statutory Options as from time to time may be permitted by the Code) or a combination of various types of Options. Options designated as ISOs shall comply with all the provisions of Section 422 of the Code and applicable regulations and shall not be granted to Non-Employee Directors (for this purpose only, a Non-Employee Director shall not be considered a Participant). The aggregate Fair Market Value (determined at the time the Option is granted) of Stock with respect to which ISOs are exercisable for the first time by an individual during a calendar year under all plans of the Company or any Subsidiary shall not exceed one hundred thousand dollars ($100,000). Upon determination by the Committee that an Option is to be granted to a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Participant, written notice shall be given to such person as soon as practicable, specifying the terms, conditions, rights and duties related thereto. Awards shall be deemed to be granted as of the date specified in the grant resolution of the Committee, which date shall be the date of any related award agreement with the Participant. In the event of any inconsistency between the provisions of the Plan and any such award agreement entered into hereunder, the provisions of the Plan shall govern. Any individual at any one time and from time to time may hold more than one Option granted under the Plan or under any other Stock plan of the Company.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(b) Each Option shall be evidenced by a &#8220;Stock Option Award Agreement&#8221; in such form and containing such provisions consistent with the provisions of the Plan as the Committee from time to time shall approve.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(c) In the event that an ISO does not comply with all the provisions of Section 422 of the Code and applicable regulations, such Option shall become a nonqualified stock Option on the date of said noncompliance.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(d) A grant may specify Indicators of Performance that must be achieved as a condition to the exercise of Options.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">6.2 EXERCISE PRICE. The price at which shares of Stock may be purchased under an Option shall not be less than one hundred percent (100%) of the Fair Market Value of the Stock on the date the Option is granted. Notwithstanding the foregoing, a Ten Percent Stockholder shall not be granted an ISO unless the exercise price of such Option is at least one hundred ten percent (110%) of the Fair Market Value of the Stock on the date such Option is granted.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">6.3 OPTION PERIOD. The period during which an Option may be exercised shall be determined by the Committee, provided that such period shall not be less than one (1) year from the date on which the Option is granted or longer than&#58; (a) five (5) years from the date on which the Option is granted with respect to a grant of an ISO to a Ten Percent Stockholder&#59; and (b) ten (10) years from the date on which the Option is granted in the case of all other Options.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">6.4 VESTING OF OPTIONS. Except as provided in Section 6.5, the date or dates on which installment portions of an Option shall vest and may be exercised during the term of an Option may vary from Option to Option and shall be set forth in the respective Stock Option Award Agreement, as determined by the Committee. Notwithstanding anything in this Section 6.4 to the contrary but subject to the provisions of this Plan and Board approval, the Committee may, on an individual basis, accelerate the time at which installment portion(s) of an outstanding Option may be exercised.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">6.5 TERMINATION OF SERVICE. Subject to the provisions of this Section 6.5, an Option shall terminate at the end of and may be exercised, to the extent the Option is exercisable under the Stock Option Award Agreement, within the period not to exceed the lesser of (a) ninety (90) days after the Participant ceases to be an Employee or Non-Employee Director for any reason other than Total Disability or death or (b) the remaining term of the Option award. If an Employee&#8217;s or Non-Employee Director&#8217;s employment or service is terminated by reason of Total Disability, all Options granted to such Participant will become fully exercisable upon such termination and may be exercised within the period not to exceed the lesser of&#58; (a) one (1) year following such termination&#59; or (b) the remaining term of the Option award. If an Employee or Non-Employee Director of the Company dies while in the employ or service of the Company or a Subsidiary or within ninety (90) days after the termination of such employment or service other </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">than Termination for Cause, Options granted to such Participant shall become fully exercisable on the Participant&#8217;s death and may, within the lesser of (a) twelve (12) months after the Participant&#8217;s death or (b) the remaining term of the Option award, be exercised by the person or persons to whom the Participant&#8217;s rights under the Option shall pass by will or by the applicable laws of descent and distribution. Unless otherwise specifically provided in the Stock Option Award Agreement, no Option may be exercised after a Participant&#8217;s service with the Company or a Subsidiary is Terminated for Cause. In no event may an Option be exercised to any extent by anyone after the expiration or termination of the Option as provided in this Section 6.5 except that the Committee may elect to extend the period of Option exercise and vesting provisions for an Employee or Non-Employee Director whose employment or service with the Company terminates for any reason.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">6.6 PAYMENT FOR SHARES. The exercise price of an Option shall be paid to the Company in full at the time of exercise at the election of the Participant&#58; (a) in cash&#59; (b) in shares of Stock having a Fair Market Value equal to the aggregate exercise price of the Option and satisfying such other requirements as may be imposed by the Committee&#59; (c) partly in cash and partly in such shares of Stock&#59; (d) through the withholding of shares of Stock (which would otherwise be delivered to the Participant) with an aggregate Fair Market Value on the exercise date equal to the aggregate exercise price of the Option&#59; or (e) through the delivery of irrevocable instructions to a broker to deliver promptly to the Company an amount equal to the aggregate exercise price of the Option. The Committee may limit the extent to which shares of Stock may be used in exercising Options. No Participant shall have any rights to dividends or other rights of a stockholder with respect to shares of Stock subject to an Option until the Participant has given written notice of exercise of the Option, paid in full for such shares of Stock and, if applicable, has satisfied any other conditions imposed by the Committee pursuant to the Plan.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">ARTICLE VII</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">STOCK APPRECIATION RIGHTS</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">7.1 GRANT OF SARs.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(a) The Committee may authorize grants of SARs to any Participant upon such terms and conditions as it may determine in accordance with this Article VII. A SAR will be a right of the Participant to receive from the Company upon exercise an amount determined by the Committee at the date of grant and expressed as a percentage of the Spread (not to exceed 100 percent) at the time of exercise. Each grant will specify the number of shares of Stock in respect of which it is made and the term during which it may be exercised.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(b) Each SAR shall be evidenced by a &#8220;Stock Appreciation Right Agreement&#8221; in such form and containing such provisions consistent with the provisions of the Plan as the Committee from time to time shall approve.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(c) A grant may specify Indicators of Performance that must be achieved as a condition to the exercise of the SARs.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">7.2 EXERCISE PRICE&#59; PAYMENT ON EXERCISE. Each grant made will specify the exercise price, which will not be less than 100% of the Fair Market Value per share of Stock on the date of grant for each SAR subject to the grant. A grant may provide that the amount payable on exercise of a SAR may be paid&#58; (a) in cash&#59; (b) in shares of Stock having an aggregate Fair Market Value per Share equal to the Spread (or the designated percentage of the Spread)&#59; or (c) </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">in a combination thereof, as determined by the Committee in its discretion. A grant may specify that the amount payable to the Participant on exercise of a SAR may not exceed a maximum amount specified by the Committee at the date of grant.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">7.3 SAR PERIOD. The period during which a SAR may be exercised shall be determined by the Committee, provided that no SAR shall be exercisable prior to one (1) year from the date of grant and more than ten (10) years from the date of grant.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">7.4 VESTING OF SARS. Except as provided in Section 7.5, the date or dates on which SARs shall vest and may be exercised during the term of a SAR may vary from SAR to SAR and shall be set forth in the respective Stock Appreciation Right Award Agreement, as determined by the Committee, provided that no SAR may be exercised except at a time when the Spread is positive. Notwithstanding anything in this Section 7.4 to the contrary but subject to the provisions of this Plan and Board approval, the Committee may, on an individual basis, accelerate the time at which installment portions of outstanding SARs may be exercised.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">7.5 TERMINATION OF SERVICE. Subject to the provisions of this Section 7.5, a SAR shall terminate at the end of, and may be exercised to the extent the SAR is exercisable under the Stock Appreciation Right Award Agreement, within the period not to exceed the lesser of (a) ninety (90) days after the Participant ceases to be an Employee or Non-Employee Director for any reason other than Total Disability or death or (b) the remaining term of the SAR award. If an Employee&#8217;s or Non-Employee Director&#8217;s employment or service with the Company or a Subsidiary is terminated by reason of Total Disability, all SARs granted to such Participant will become fully exercisable upon such termination and may be exercised within the period not to exceed the lesser of&#58; (a) one (1) year following such termination&#59; or (b) the remaining term of the SAR award. If an Employee or Non-Employee Director of the Company dies while in the employ or service of the Company or a Subsidiary or within ninety (90) days after the termination of such employment or service for any reason other than Termination for Cause, SARs granted to such Participant shall become fully exercisable on the Participant&#8217;s death and may, within the lesser of (a) twelve (12) months after the Participant&#8217;s death or (b) the remaining term of the SAR award, be exercised by the person or persons to whom the Participant&#8217;s rights under the SAR shall pass by will or by the applicable laws of descent and distribution. Unless otherwise specifically provided in the Stock Appreciation Right Award Agreement, no SAR may be exercised after a Participant&#8217;s service with the Company or a Subsidiary has been Terminated for Cause. In no event may a SAR be exercised to any extent by anyone after the expiration or termination of the SAR as provided in this Section 7.5 except that the Committee may elect to extend the period of SAR exercise and vesting provisions for an Employee or Non-Employee Director whose employment or service with the Company terminates for any reason.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">7.6 NO RIGHTS AS STOCKHOLDER. No Participant shall have any rights to dividends or other rights of a stockholder of Stock with respect to a SAR.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">ARTICLE VIII</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">RESTRICTED STOCK</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">8.1 GRANT OF RESTRICTED STOCK.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(a) The Committee may authorize grants of Restricted Stock to any Participant upon such terms and conditions as it may determine in accordance with this Article VIII. Each grant will specify the number of shares of Restricted Stock being granted. At the time of making a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">grant of Restricted Stock to a Participant, the Committee shall establish a Restriction Period during which shares of Restricted Stock are subject to forfeiture if the restrictions applicable to such shares are violated. Subject to the provisions of Section 8.3, the vesting schedule pursuant to which forfeiture restrictions applicable to a grant of Restricted Stock lapse shall be established by the Committee in its discretion and set forth in the respective Restricted Stock Award Agreement. The Committee may, subject to the provisions of this Plan and Board approval, on an individual basis, accelerate the time at which restrictions on Restricted Stock lapse. The Committee shall assign such terms, conditions and other restrictions to the Restricted Stock as it shall determine.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(b) Each grant of Restricted Stock shall be evidenced by a &#8220;Restricted Stock Award Agreement&#8221; in such form and containing such provisions consistent with the provisions of the Plan as the Committee from time to time shall approve.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(c) A grant may specify Indicators of Performance that must be achieved as a condition to the vesting of the Restricted Stock.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">8.2 VESTING OF RESTRICTED STOCK. Except as provided in Section 8.3, the date or dates on which Restricted Stock shall vest may vary from grant to grant and shall be set forth in the respective Restricted Stock Award Agreement, as determined by the Committee. Notwithstanding anything in this Section 8.2 to the contrary but subject to the provisions of this Plan and Board approval, the Committee may, on an individual basis, accelerate the time at which restrictions on Restricted Stock lapse.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">8.3 TERMINATION OF SERVICE. The Committee may establish such rules concerning the termination of service of a recipient of Restricted Stock prior to the expiration of the applicable Restriction Period as it may deem appropriate&#59; provided, however, that if an Employee or Non-Employee Director terminates service by reason of death or Total Disability, the applicable forfeiture restrictions will lapse upon such death or occurrence of Total Disability. Unless otherwise specifically provided in the Restricted Stock Award Agreement, Restricted Stock will be forfeited immediately upon termination of a Participant&#8217;s service with the Company or a Subsidiary if the Participant&#8217;s employment is Terminated for Cause.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">8.4 LEGEND ON CERTIFICATES. The Committee may legend the certificates representing Restricted Stock to give appropriate notice of such restrictions. For example, the Committee may determine that some or all certificates representing shares of Restricted Stock shall bear the following legend&#58;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:113.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8220;THE SALE OR OTHER TRANSFER OF THE SHARES OF STOCK REPRESENTED BY THIS CERTIFICATE, WHETHER VOLUNTARY, INVOLUNTARY, OR BY OPERATION OF LAW, IS SUBJECT TO CERTAIN RESTRICTIONS ON TRANSFER AS SET FORTH IN THE CASS INFORMATION SYSTEMS, INC. 2023 OMNIBUS STOCK AND PERFORMANCE COMPENSATION PLAN, AND IN A RESTRICTED STOCK AWARD AGREEMENT. A COPY OF THE PLAN AND SUCH RESTRICTED STOCK AWARD AGREEMENT MAY BE OBTAINED FROM THE SECRETARY OF THE COMPANY.&#8221;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">8.5 RETURN OF RESTRICTED STOCK TO COMPANY. On the date set forth in the applicable Restricted Stock Award Agreement, the Restricted Stock for which restrictions have not lapsed shall revert to the Company.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">8.6 SECTION 83(b) ELECTION. The Committee may provide in a Restricted Stock Award Agreement that the award of Restricted Stock is conditioned upon the Participant making or refraining from making an election with respect to the award under Section 83(b) of the Code. If a Participant makes an election pursuant to Section 83(b) of the Code with respect to a Restricted Stock award, the Participant shall be required to promptly file a copy of such election with the Company.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">8.7 RIGHTS AS A STOCKHOLDER. Restricted Stock will be represented by a Stock certificate registered in the name of the Restricted Stock recipient. Such certificate, accompanied by a separate, duly-endorsed stock power, shall be deposited with the Company. Instead of issuing certificates, the Company may elect to have unvested shares of Restricted Stock held in book entry form on the books of the Company depository or another institution designated by the Company if and only to the extent permitted by applicable laws and the Company&#8217;s Articles of Incorporation and Bylaws. The recipient shall be entitled to earn dividends during the Restriction Period and shall have the right to vote such Restricted Stock and all other stockholder&#8217;s rights, with the exception that&#58; (a) the recipient will not be entitled to delivery of the Stock certificate during the Restriction Period&#59; (b) the Company will retain custody of the Restricted Stock during the Restriction Period&#59; (c) the non-fulfillment of the terms and conditions established by the Committee pursuant to the grant shall cause a forfeiture of the Restricted Stock&#59; and (d) dividends earned on the Restricted Stock during the Restriction Period shall be retained by the Company until the underlying Shares have vested and restrictions lifted and shall be payable only subject to the fulfillment of the terms and conditions of the grant, as may be set forth in the Restricted Stock Award Agreement.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">ARTICLE IX</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">RESTRICTED STOCK UNITS</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">9.1 GRANT OF RSUs.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(a) The Committee may authorize grants of RSUs to any Participant upon such terms and conditions as it may determine in accordance with this Article IX. A RSU is the right of the Participant to receive from the Company, upon vesting of the RSU, an amount or a percentage of the amount not to exceed 100 percent (100%), equal to the number of RSUs becoming vested multiplied by the Fair Market Value of a share of Stock on the vesting date. Each grant will specify the number of RSUs being granted. At the time of making a grant of RSUs to a Participant, the Committee shall establish a Restriction Period during which RSUs are subject to forfeiture if the restrictions applicable to such shares are violated. Subject to the provisions of Section 9.4, the vesting schedule pursuant to which forfeiture restrictions applicable to a grant of RSUs lapse shall be established by the Committee in its discretion and set forth in the respective Restricted Stock Unit Award Agreement. The Committee may, subject to the provisions of this Plan and Board approval, on an individual basis, accelerate the time at which restrictions on RSUs lapse. The Committee shall assign such terms, conditions and other restrictions to the RSUs as it shall determine.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(b) Each RSU shall be evidenced by a &#8220;Restricted Stock Unit Award Agreement&#8221; in such form and containing such provisions consistent with the provisions of the Plan as the Committee from time to time shall approve.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(c) A grant may specify Indicators of Performance that must be achieved as a condition to the vesting of the RSUs.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">9.2 PAYMENT ON VESTING. A grant may provide that the amount payable on vesting of a RSU may be paid&#58; (a) in cash&#59; (b) in shares of Stock having an aggregate Fair Market Value equal to the amount payable (or the designated percentage of the amount payable)&#59; or (c) in a combination thereof, as determined by the Committee in its discretion. Such payment shall be made no later than March 15 of the year immediately following the calendar year in which the vesting occurs or by a later date by which such payment may be made so that the payment falls under the short term deferral exception of Section 409A of the Code. A grant may specify that the amount payable to the Participant on vesting of an RSU may not exceed a maximum amount specified by the Committee at the date of grant.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">9.3 VESTING OF RSUs. Except as provided in Section 9.4, the date or dates on which RSUs shall vest may vary from grant to grant and shall be set forth in the respective Restricted Stock Unit Award Agreement, as determined by the Committee. Notwithstanding anything in this Section 9.3 to the contrary but subject to the provisions of this Plan and Board approval, the Committee may, on an individual basis, accelerate the time at which restrictions on RSUs lapse.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">9.4 TERMINATION OF SERVICE. The Committee may establish such rules concerning the termination of service of a recipient of RSUs prior to the expiration of the applicable Restriction Period as it may deem appropriate&#59; provided, however, that if an Employee or Non-Employee Director terminates service by reason of death or Total Disability, the applicable forfeiture restrictions will lapse upon such death or occurrence of Total Disability. Unless otherwise specifically provided in the Restricted Stock Unit Award Agreement, RSUs will be forfeited immediately upon termination of a Participant&#8217;s service with the Company or a Subsidiary if the Participant&#8217;s employment is Terminated for Cause.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">9.5 NO RIGHTS AS A STOCKHOLDER. No Participant shall have rights to dividends, vesting, voting or other rights as a shareholder of Stock with respect to RSUs. Notwithstanding the foregoing, the Committee may grant dividend equivalents on RSUs based on the dividends actually declared and paid on outstanding shares of Stock.  The terms of any dividend equivalents will be as set forth in the Restricted Stock Unit Award Agreement, including the time and form of payment and whether such dividend equivalents will be credited with interest or deemed to be reinvested in additional RSUs. If the Committee grants the right of a Participant to receive dividend equivalents on unvested RSUs subject to this Section 9.5, then such dividend equivalents shall be subject to the same performance conditions and service conditions, as applicable, as the underlying RSUs.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">ARTICLE X</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">PHANTOM STOCK</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">10.1 GRANT OF PHANTOM STOCK.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(a) The Committee may authorize grants of Phantom Stock to any Participant upon such terms and conditions as it may determine in accordance with this Article X. Phantom Stock is an award in the form of a right to receive cash or Stock upon surrender of the vested Phantom Stock, in an amount equal to the Fair Market Value of the Stock plus the aggregate amount of cash dividends paid with respect to a share of Stock during the period commencing on the date on which the share of Phantom Stock was granted and terminating on the date on which such share vests. Each grant will specify the number of shares of Phantom Stock to which it pertains. At the time of making a grant of Phantom Stock to a Participant, the Committee shall establish a Restriction Period during which shares of Phantom Stock are subject to forfeiture if the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">restrictions applicable to such shares are violated. Subject to the provisions of Section 10.4, the vesting schedule pursuant to which forfeiture restrictions applicable to a grant of Phantom Stock lapse shall be established by the Committee in its discretion and set forth in the respective Phantom Stock Award Agreement. The Committee may, subject to the provisions of this Plan and Board approval, on an individual basis, accelerate the time at which restrictions on Phantom Stock lapse. The Committee shall assign such terms, conditions and other restrictions to the Phantom Stock as it shall determine.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(b) Each Phantom Stock award shall be evidenced by a &#8220;Phantom Stock Award Agreement&#8221; in such form and containing such provisions consistent with the provisions of the Plan as the Committee from time to time shall approve.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(c) A grant may specify Indicators of Performance that must be achieved as a condition to the vesting of the Phantom Stock.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">10.2 PAYMENT ON VESTING. A grant may provide that the amount payable on vesting of an award of Phantom Stock may be paid&#58; (a) in cash&#59; (b) in shares of Stock having an aggregate Fair Market Value equal to the amount payable (or the designated percentage of the amount payable)&#59; or (c) in a combination thereof, as determined by the Committee in its discretion. Upon the vesting of a share of Phantom Stock, the Participant shall be entitled to receive payment, in cash or Stock as the Phantom Stock Award Agreement shall indicate, an amount equal to the sum of (a) the Fair Market Value of a share of Stock on the date on which such share of Phantom Stock vests and (b) the aggregate amount of cash dividends paid with respect to a share of Stock during the period commencing on the date on which the share of Phantom Stock was granted and terminating on the date on which such share vests. Such payment shall be made no later than March 15 of the year immediately following the calendar year in which the vesting occurs or by a later date by which such payment may be made so that the payment falls under the short term deferral exception of Section 409A of the Code. A grant may specify that the amount payable to the Participant on vesting of a Phantom Stock award may not exceed a maximum amount specified by the Committee at the date of grant.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">10.3 VESTING OF PHANTOM STOCK. Except as provided in Section 10.4, the date or dates on which Phantom Stock shall vest may vary from grant to grant and shall be set forth in the respective Phantom Stock Award Agreement, as determined by the Committee. Notwithstanding anything in this Section 10.3 to the contrary but subject to the provisions of this Plan and Board approval, the Committee may, on an individual basis, accelerate the time at which restrictions on Phantom Stock lapse.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">10.4 TERMINATION OF SERVICE. The Committee may establish such rules concerning the termination of service of a recipient of Phantom Stock prior to the expiration of the applicable Restriction Period as it may deem appropriate&#59; provided, however, that if an Employee or Non-Employee Director terminates service by reason of death or Total Disability, the applicable forfeiture restrictions will lapse upon such death or occurrence of Total Disability. Unless otherwise specifically provided in the Phantom Stock Award Agreement, Phantom Stock will be forfeited immediately upon termination of a Participant&#8217;s service with the Company or a Subsidiary if the Participant&#8217;s employment is Terminated for Cause.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">10.5 NO RIGHTS AS A STOCKHOLDER. No Participant shall have rights to dividends, vesting, voting or other rights as a shareholder of Stock with respect to Phantom Stock.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">ARTICLE XI</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">PERFORMANCE AWARDS</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">11.1 PERFORMANCE AWARDS. Performance Awards pursuant to this Article XI are based upon achieving established Indicators of Performance over a Performance Period. At the time of making a Performance Award, the Committee shall establish such terms and conditions as it shall determine applicable to such Performance Award. Performance Awards shall be paid not later than March 15 of the calendar year immediately following the calendar year in which the Performance Period ends or by a later date by which such payment may be made so that the payment falls under the short term deferral exception of Section 409A of the Code. Recipients of Performance Awards are not required to provide consideration for such awards other than the rendering of service. A Performance Award shall be paid in cash. For avoidance of doubt, a Performance Award under this Article XI is not in lieu of any annual bonus plan or other bonus program established and approved by the Board of Directors from time to time.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">11.2 ADMINISTRATIVE PROCEDURE. The Committee shall designate Employees as Performance Award Participants to become eligible to receive Performance Awards and shall establish Performance Periods.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">11.3 INDICATORS OF PERFORMANCE. The Committee shall establish Indicators of Performance applicable to the Performance Period. Indicators of Performance are utilized to determine amount and timing of Performance Awards, and may vary between Performance Periods and different Performance Awards.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">11.4 AWARD ADJUSTMENT. Subject to the terms of the Performance Award, the Committee may make downward adjustments to Performance Awards to Performance Award Participants.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">11.5 PARTIAL PERFORMANCE PERIOD PARTICIPATION. The Committee shall determine the extent to which an Employee shall participate in a partial Performance Period because of becoming eligible to be a Performance Award Participant after the beginning of such Performance Period. In the event a Performance Award Participant&#8217;s employment with the Company is terminated for any reason, other than after a Change of Control, prior to completing at least fifty percent (50%) of the Performance Period for a Performance Award, no payment shall be made pursuant to the Performance Award. In the event a Performance Award Participant&#8217;s employment with the Company is terminated (a) on account of termination by the Company for other than Termination for Cause, (b) death or (c) Total Disability after completing at least fifty percent (50%) of the Performance Period for a Performance Award, such Performance Award Participant shall be paid a pro rata portion of the Performance Award, if the Indicators of Performance are met, no later than March 15 of the year immediately following the calendar year in which his or her employment is terminated or by a later date by which such payment may be made so that the payment falls under the short term deferral exception of Section 409A of the Code. No payment shall be made pursuant to a Performance Award if the Performance Award Participant&#8217;s employment with the Company is voluntarily terminated by him or her for any reason or is Terminated for Cause prior to the end of the Performance Period.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">ARTICLE XII</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">ADJUSTMENT UPON CHANGES IN STOCK</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The number of shares of Stock, including limits under Sections 5.1 and 5.2, which may be issued pursuant to this Plan, the number of shares covered by, and the exercise price per share of, each outstanding Option and SAR, the number of shares granted as Restricted Stock and the number of RSUs and Phantom Stock, shall be adjusted proportionately, and any other appropriate adjustments shall be made, for any increase or decrease in the total number of issued and outstanding shares of Stock (or change in kind) resulting from any change in the Stock through a merger, consolidation, reorganization, recapitalization, subdivision or consolidation of shares or other capital adjustment or the payment of a Stock dividend or other increase or decrease (or change in kind) in such shares. In the event of any such adjustment, fractional shares shall be eliminated. Except as otherwise determined by the Committee, no change shall be made to an ISO under this Article XII to the extent it would constitute a &#8220;modification&#8221; under section 424(h)(3) of the Code.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">ARTICLE XIII</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">CHANGE OF CONTROL</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Notwithstanding anything to the contrary in the Plan, if a Participant&#8217;s employment is involuntarily terminated upon a Change of Control of the Company, the following shall apply&#58;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(a) If a Change of Control occurs during a Restriction Period(s) applicable to Restricted Stock, RSUs and Phantom Stock issued under the Plan, all restrictions imposed hereunder on such Restricted Stock, RSUs and Phantom Stock shall lapse effective as of the date of the Change of Control&#59;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(b) If a Change of Control occurs during a Performance Period(s) applicable to a Performance Award granted under the Plan, a Performance Award Participant shall earn no less than the award of cash which the Performance Award Participant would have earned if applicable Indicator(s) of Performance had been achieved and the Performance Period(s) had terminated as of the date of the Change of Control&#59; and</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(c) Any outstanding Options and SARs that are not exercisable shall become exercisable effective as of the date of a Change of Control. If a Participant&#8217;s employment is terminated within two (2) years after the effective date of a Change of Control for a reason other than a Termination for Cause, to the extent that any Option or SAR was exercisable at the time of the Participant&#8217;s termination of employment, such Option or SAR, other than an ISO, may be exercised within the lesser of&#58; (a) twelve (12) months following the date of termination of employment, or (b) the term of the Option or SAR.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">ARTICLE XIV</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">MISCELLANEOUS</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">14.1 EFFECT ON OTHER PLANS. Except as otherwise required by law, no action taken under the Plan shall be taken into account in determining any benefits under any pension, retirement, thrift, profit sharing, group insurance or other benefit plan maintained by the Company or any Subsidiary, unless such other plan specifically provides for such inclusion.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">14.2 TRANSFER RESTRICTIONS. No Option (except as provided in Section 14.3), SAR, RSU, grant of Restricted Stock, grant of Phantom Stock or Performance Award under this Plan </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">shall be transferable other than by will or the laws of descent and distribution. Any Option or SAR shall be exercisable&#58; (a) during the lifetime of a Participant, only by the Participant or, to the extent permitted by the Code, by an appointed guardian or legal representative of the Participant&#59; and (b) after death of the Participant, only by the Participant&#8217;s legal representative or by the person who acquired the right to exercise such Option or SAR by bequest or inheritance or by reason of the death of the Participant. The Committee and the Participant may, in any agreement providing for a grant and&#47;or award under this Plan, provide that the Participant may designate a beneficiary or beneficiaries to receive the property granted pursuant to an award and&#47;or exercise of the Participant&#8217;s rights under the grant and&#47;or award as provided in this Plan after the death of the Participant.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">14.3 TRANSFER OF OPTIONS. The Committee may, in its discretion, authorize all or a portion of the Options to be granted to a Participant to be on terms which permit transfer by such Participant to an immediate family member of the Participant who acquires the options from the Participant through a gift or a domestic relations order. For purposes of this Article XIV, Section 14.3, &#8220;family member&#8221; includes any child, stepchild, grandchild, parent, stepparent, grandparent, spouse, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law or sister-in-law, including adoptive relationships, trusts for the exclusive benefit of these persons and any other entity owned solely by these persons, provided that the Stock Option Award Agreement pursuant to which such Options are granted must be approved by the Committee and must expressly provide for transferability in a manner consistent with this Section and provided further that subsequent transfers of transferred Options shall be prohibited except in accordance with Article XIV, Section 14.2. Following transfer, any such Options shall continue to be subject to the same terms and conditions as were applicable immediately prior to transfer. The events of termination of employment of Article VI, Section 6.5 hereof shall continue to be applied with respect to the original Participant, following which the Options shall be exercisable by the transferee only to the extent and for the periods specified in Article VI, Section 6.5. Notwithstanding the foregoing, an ISO may not be transferred to a family member in accordance with this Section 14.3.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">14.4 WITHHOLDING TAXES. The Company shall have the right to withhold from any settlement hereunder any federal, state, or local taxes required by law to be withheld, or require payment in the amount of such withholding. If settlement hereunder is in the form of Stock, such withholding may be satisfied by the withholding of shares of Stock by the Company, unless the Participant shall pay to the Company an amount sufficient to cover the amount of taxes required to be withheld, and such withholding of shares does not violate any applicable laws, rules or regulations of federal, state or local authorities.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">14.5 TRANSFER OF EMPLOYMENT. Transfer of employment or consulting assignment between the Company and a Subsidiary shall not constitute termination of employment or service for the purpose of the Plan. Whether any leave of absence shall constitute termination of employment for the purposes of the Plan shall be determined in each case by the Committee.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">14.6 ADMINISTRATIVE EXPENSES. All administrative expenses associated with the administration of the Plan shall be paid by the Company.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">14.7 TITLES AND HEADINGS. The titles and headings of the articles in this Plan are for convenience of reference only and in the event of any conflict, the text of the Plan, rather than such titles or headings, shall control.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">14.8 NO GUARANTEE OF CONTINUED EMPLOYMENT OR SERVICE. No grant or award to an Employee under the Plan or any provisions thereof shall constitute any agreement for or guarantee of continued employment by the Company and no grant or award to a Non-Employee Director shall constitute any agreement for or guarantee of continuing as a Non-Employee Director.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">14.9 COMMITTEE DUTIES AND POWERS. The Committee shall have such duties and powers as may be necessary to discharge its responsibilities under this Plan, including, but not limited to, the ability to construe and interpret the Plan and resolve any ambiguities with respect to any of the terms and provisions hereof as written and as applied to the operation of the Plan.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">14.10 PROCEEDS. The proceeds received by the Company from the sale of Stock under the Plan shall be added to the general funds of the Company and shall be used for corporate purposes as the Board shall direct.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">14.11 GOVERNING LAW AND VENUE. This plan shall be governed by and construed and enforced in accordance with the laws of the State of Missouri, excluding conflict of law rules and principles, except to the extent such laws are preempted by Federal law. Courts located in the State of Missouri shall have exclusive jurisdiction to determine all matters relating to the Plan and that venue is proper in such courts.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">14.12 FOREIGN JURISDICTIONS. Awards may be granted to employees who are foreign nationals or employed outside the United States, or both, on such terms and conditions different from those specified in the Plan as may, in the judgment of the Committee, be necessary or desirable in order to recognize differences in local law or tax policy. The Committee also may impose conditions on the exercise or vesting of awards in order to minimize the Company&#8217;s obligation with respect to tax equalization for Participants on assignments outside their home country.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">14.13 SUCCESSORS. All obligations of the Company under the Plan, with respect to awards granted hereunder, shall be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation or otherwise, of all or substantially all of the business or assets of the Company.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">14.14 BENEFICIARY DESIGNATIONS. If permitted by the Committee, a Participant under the Plan may name a beneficiary or beneficiaries to whom any vested but unpaid award shall be paid in the event of the Participant&#8217;s death. Each such designation shall revoke all prior designations by the Participant and shall be effective only if given in a form and manner acceptable to the Committee. In the absence of any such designation, any vested benefits remaining unpaid at the Participant&#8217;s death shall be paid to the Participant&#8217;s estate and, subject to the terms of the Plan and of the applicable award agreement, any unexercised vested award may be exercised by the administrator, executor or the personal representative of the Participant&#8217;s estate.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">14.15 INVESTMENT REPRESENTATION. As a condition to the exercise of an award, the Committee may require the person exercising such award to represent and warrant at the time of any such exercise that the Shares are being purchased only for investment and without any present intention to sell or distribute such Shares if, in the opinion of counsel for the Company, such a representation is required.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">14.16 FRACTIONAL SHARES. No fractional Shares shall be issued or delivered pursuant to the Plan or any award. The Committee shall determine whether cash, or awards, or other property shall be issued or paid in lieu of fractional Shares or whether such fractional Shares or any rights thereto shall be forfeited or otherwise eliminated.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">14.17 DEFERRAL ELECTION. To the extent provided by the Committee under the Plan or an applicable deferral plan established by the Company, the receipt of payment of cash or delivery of shares of Stock that would otherwise be due to a Participant pursuant to an award hereunder, other than Options and SARs, may be deferred at the election of the Participant, including any dividend or dividend equivalent granted with respect to any such award.  Any such deferral elections and the payment of any amounts so deferred shall be made in accordance with such rules and procedures as the Committee may establish consistent with the Plan, which rules and procedures shall comply with Section 409A of the Code.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">14.18 SECTION 409A PROVISIONS. Notwithstanding any other provision of the Plan, no adjustment described in Article XII and no termination, amendment, or modification of the Plan shall (a) impermissibly accelerate or postpone payment of an award subject to Section 409A of the Code and the regulations and guidance issued thereunder&#59; (b) cause an Option or SAR to provide for a deferral of compensation subject to Section 409A of the Code and the regulations and guidance issued thereunder&#59; or (c) apply to any award that otherwise is intended to satisfy the requirements of Section 409A of the Code and the regulations and guidance issued thereunder to the extent such action would cause compensation deferred under the applicable award (and applicable earnings) to be included in income under Section 409A of the Code. Any payment or distribution that otherwise would be made to a Participant who is a Specified Employee (as determined by the Committee in good faith) on account of separation from service may not be made before the date which is six (6) months after the date of the Specified Employee&#8217;s separation from service unless the payment or distribution is exempt from the application of Section 409A of the Code by reason of the short term deferral exemption or otherwise.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">14.19 SUCCESSIVE GRANTS. Successive grants of awards may be made to the same Participant whether or not any award of the same type or any other award previously granted to such Participant remain unexercised or outstanding.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">14.20 CLAWBACK OF AWARDS. The awards granted under the Plan shall be subject to rescission, revocation, adjustment or other modification at the discretion of the Committee consistent with the terms of the Company&#8217;s Clawback Policy, as may be amended from time to time to comply with applicable legal requirements providing for the recoupment or clawback of incentive compensation.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">ARTICLE XV</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">AMENDMENT AND TERMINATION</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Board may at any time terminate or amend this Plan in such respect as it shall deem advisable, provided, the Board may not, without further approval of the shareholders of the Company, amend the Plan to&#58; (a) increase the number of shares of Stock which may be issued under the Plan&#59; (b) change Plan provisions relating to establishment of the exercise prices under Options or SARs granted&#59; (c) extend the duration of the Plan beyond the date approved by the shareholders&#59; (d) reprice, replace or regrant Options or SARs through cancellation, or by lowering the exercise price of a previously granted Option or SARs&#59; (e) make any change to the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Plan considered material under the listing requirements of The NASDAQ Stock Market or any other exchange on which the Company&#8217;s Stock is listed&#59; or (f) increase the maximum dollar amount of ISOs which an individual Participant may exercise during any calendar year beyond that permitted in the Code and applicable rules and regulations of the Treasury Department. No amendment or termination of the Plan shall, without the consent of the Participant, alter or impair any of the rights or obligations under any grants or other rights theretofore granted such person under the Plan.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">ARTICLE XVI</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">DURATION OF THE PLAN</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">This Plan was approved by the Board of Directors on February 16, 2023 and will be effective on April 18, 2023, subject to approval by the Company&#8217;s shareholders at the 2023 annual meeting of shareholders. If not sooner terminated by the Board, this Plan shall terminate on April 17, 2033, but Options, SARs, Restricted Stock, RSUs, Phantom Stock, Performance Awards and other rights theretofore granted and any Restriction Period may extend beyond that date, and the terms of the Plan shall continue to apply to such grants. In no event shall ISOs be awarded after April 17, 2033.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>exhibit102-restrictedstock.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ida3281f364bb4669ae5146f9b9b8ea1b_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 10.2</font></div><div style="margin-bottom:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CASS INFORMATION SYSTEMS, INC.<br>2023 OMNIBUS STOCK AND PERFORMANCE COMPENSATION PLAN<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">RESTRICTED STOCK AWARD AGREEMENT</font></div><div style="margin-bottom:0.12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participant Name&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br>Date of Grant&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br>Number of Restricted Shares subject to this Award&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We are pleased to inform you that, as an employee or director of Cass Information Systems, Inc. (&#8220;Cass&#8221; or &#8220;the Company&#8221;) or one of its Subsidiaries, you are granted an Award of Restricted Shares (&#8220;Shares&#8221;) under the Cass Information Systems, Inc. 2023 Omnibus Stock and Performance Compensation Plan (the &#8220;Plan&#8221;).  Each Share under this Award represents one share of Cass common stock, $0.50 par value per share.  This Award Agreement is subject to your acceptance as provided in Section&#160;1 below and the terms and conditions that follow in this Award Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The date of the Award evidenced by this Award Agreement (the &#8220;Date of Grant&#8221;) is set forth above.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The terms and conditions of this Award Agreement, including non-standard provisions permitted by the Plan, are set forth below.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt">Acceptance of Award.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  This Award Agreement is to be accepted by signing your name on the signature page of this Award Agreement and causing it to be delivered to the Secretary of Cass, 12444 Powerscourt Drive, Suite 550, St.&#160;Louis, MO 63131, before 4&#58;30 p.m. Central time on the 30th day after the Date of Grant.  If the Secretary does not receive your properly signed copy of this Award Agreement before the time and date specified in the previous sentence, then, despite anything else provided in this Agreement, this Award will be void as if it was never awarded to you and will be of no effect.  Your signing and timely delivering of this Award Agreement will evidence your acceptance on the terms and conditions stated in this Award Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt">Vesting and Forfeiture of Restricted Stock</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:29.07pt">Vesting of Time-Based Restricted Shares.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  With respect to forty percent (40%) of your Award Shares covering </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">___</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Shares (&#8220;Time-Based Restricted Shares&#8221;) will vest and become immediately transferrable on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">______________</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (&#8220;Vesting Date&#8221;), which is three years from the date of grant (&#8220;Restriction Period&#8221;), if you remain employed through the Vesting Date, the Restriction Period will lapse with respect to applicable Time-Based Restricted Shares and Cass shall deliver the Shares to you effective three years from the date of grant.  Cass shall deliver the Shares to you as explained in Section&#160;3 of this Award Agreement.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt">Vesting of Performance-Based Restricted Shares.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  With respect to sixty percent (60%) of your Award Shares covering </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">___</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Shares, (&#8220;Performance-Based Restricted Shares&#8221;), such Shares will vest and immediately become transferrable on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">_______________</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (&#8220;Vesting Date&#8221;) in an amount, if any, based on the achievement of the performance goals set forth in Section 2.b.(i)-(iv) below.  Any Performance-Based Restricted Shares which do not become vested because of the failure to achieve these performance goals for the Performance Period shall be forfeited.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:30.73pt">The percentage of Performance-Based Restricted Shares shall vest based on achievement of earnings per share (&#8220;EPS&#8221;) and return on equity (&#8220;ROE&#8221;) goals over the Performance Period described below, as indicated in the table below.  Each factor will be weighted 50% in determining the total percentage of Shares earned.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25492541_2.docx</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:95.4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.128%"><tr><td style="width:1.0%"></td><td style="width:21.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.300%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Performance Period&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning</font></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">____________________</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Three Years)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending</font></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">____________________</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">50%<br>Threshold</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100%<br>Target</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">150%<br>Maximum</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per Share (EPS)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$____</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$____</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$____</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Return on Equity (ROE)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">__%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">__%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">__%</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:27.96pt">The percentage earned related to EPS goals shall be determined based on the cumulative EPS for the 3 year Performance Period.  100% will be earned if the Company achieves target performance, 50% shall be earned if the Company achieves threshold performance and a maximum of 150% of the shares shall be earned if the Company achieves maximum or better performance.  Performance that falls between threshold and target or target and maximum performance shall be interpolated between the respective percentages.  Any performance that falls below threshold will result in 0% earned attributable to EPS performance.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:25.19pt">The percentage earned related to ROE goals shall be based on the average ROE measured by calculating the average of each of the calendar year&#8217;s annual average ROE calculations over the 3 year Performance Period.  100% will be earned if the Company achieves target performance, 50% shall be earned if the Company achieves threshold performance and a maximum of 150% of the Shares will be earned if the Company achieves maximum or better performance.  Performance that falls between threshold and target or target and maximum performance shall be interpolated between the respective percentages.  Any performance that falls below threshold will result in 0% earned attributable to ROE performance.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:25.73pt">A weighting of 50% will be applied to each of the percentages earned related to EPS and ROE performance to determine the total percentage earned.  The number of Shares earned will then be determined by taking the number of Performance-Based Restricted Shares awarded, stated in Section&#160;2.b., multiplied by the total percentage earned.  Any resulting partial shares will be rounded to the nearest whole share.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">v.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">EPS and average ROE shall be determined based on generally accepted accounting principles (&#8220;GAAP&#8221;) and may be adjusted for extraordinary items as determined by the Company&#8217;s Board of Directors.  Extraordinary items shall mean extraordinary, unusual and&#47;or non-recurring items, including but not limited to&#58;  restructuring or restructuring-related charges, gains or losses attributable to the disposition of a business or major asset, resolution and&#47;or settlement of litigation and other legal proceedings or any other such income or expense related item that the Board of Directors has determined to be of an unusual or extraordinary nature.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">vi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:25.73pt">Unless previously forfeited or transferred on account of your death, Total Disability or a Change in Control, the Restriction Period will lapse with respect to the applicable Performance-Based Restricted Shares earned, as described in Sections 2.b (i) &#8211; (v), and Cass shall deliver the Shares to you effective on the Vesting Date, which is three years from the date of grant, subject to the determination of performance results by the Board of Directors.  In the event delays are experienced in determining the performance results beyond the Vesting Date, once such results are in fact determined, vesting shall occur retroactively back to the Vesting Date.  Cass shall deliver the Shares to you as described in Section&#160;3 of this Award Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt">Issuance of Restricted Shares</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:29.07pt">Time-Based Restricted Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> shall be held in book entry form on the books of Cass&#8217;s depository (or another institution specified by Cass) subject to the restrictions of this Award </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agreement until such time the Shares have Vested, as explained in Section&#160;2.a. or vest as a result of your death, Total Disability or a Change in Control, as explained in Section&#160;4.a.  As soon as practicable following the lapse of restriction provisions and subsequent Vesting of Shares, Cass shall give transfer instructions to the institution holding the Shares in book entry form so that the Shares are transferred to you or your designated beneficiary, if applicable, without restriction.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">You hereby (i)&#160;acknowledge that Shares may be held in book entry form on the books of Cass&#8217;s depository (or another institution specified by Cass), (ii)&#160;irrevocably authorize Cass to take such actions as may be necessary or appropriate to effect a transfer or cancellation of the record ownership of any such Unvested Shares that are forfeited in accordance with this Award Agreement, (iii)&#160;agree to take such other actions as Cass may reasonably request to accomplish the forfeiture of any Unvested Shares that are forfeited under this Award Agreement, and (iv)&#160;authorize Cass to cause such Shares to be cancelled or transferred in the event they are forfeited pursuant to this Award Agreement.  For the purposes of this Award Agreement, &#8220;Unvested Shares&#8221; shall mean these shares that were not yet vested pursuant to the terms of this Award Agreement.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt">Performance-Based Restricted Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> shall not be issued until such time the Performance Period has ended and the Board of Directors have determined the performance results and number of shares earned, as described in Section&#160;2.b (2.b.i) &#8211; (2.b.v).  As soon as practicable following the determination of results, lapse of restrictions and subsequent vesting of Shares, Cass shall provide instructions to the depository institution (or other institution specified by Cass) to issue to recipient Shares earned in book entry form without restriction.  The delivery of Shares in the event of a Death, Total Disability or a Change of Control is set forth in Section 4 below.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt">Effect of Death, Total Disability or Change of Control.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:29.07pt">Time-Based Restricted Shares.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  If you die while in the employment or service of Cass or its Subsidiaries, the Restriction Period will lapse with respect to all outstanding Time-Based Restricted Shares and Cass shall deliver the Shares subject to this Award Agreement to your Designated Beneficiary or as provided in Section&#160;6.e. if a Beneficiary has not been designated, has died or cannot be located.  Subsequently, such Shares shall not be subject to forfeiture after your death.  If you become Totally Disabled or a Change of Control occurs, that results in termination of service, while you are employed by or in the service of Cass or its Subsidiaries, the Restriction Period will lapse with respect to all outstanding Time-Based Restricted Shares and Cass shall deliver the Shares subject to this Award Agreement to you.  Subsequently, such Shares shall not be subject to forfeiture after the occurrence of your Total Disability or a Change of Control occurs, that results in termination of service and such shares shall be delivered in the same manner as provided in this Section&#160;2.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt">Performance-Based Restricted Shares.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  If you die or become Totally Disabled while in the employment or service of Cass or its Subsidiaries, all outstanding Performance-Based Restricted Shares shall vest in accordance with the normal terms of this Award Agreement as described in Section&#160;2.b.  In the case of your death Cass shall deliver the Shares that have vested to your Designated Beneficiary or as provided in Section&#160;6.e. if a Beneficiary has not been designated, has died or cannot be located.  If a Change in Control occurs that results in termination of employment during the Performance Period, all outstanding Performance-Based Restricted Shares will immediately vest and restrictions shall lapse at the Target Performance level and Cass shall deliver the shares to the recipient as explained in Section&#160;3.b. as if the Restriction Period has ended.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt">Termination of Employment.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  If your employment or service with Cass or any of its Subsidiaries terminates, as described in Section&#160;7, prior to the vesting of Shares in accordance with Section&#160;2 other than by reason of your death, Total Disability, after a Change of Control or Normal Retirement, as described in Section&#160;9, you shall forfeit all such Shares.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt">Restrictions.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  In association with the other terms of this Agreement and in accordance with the Plan, the Shares shall be subject to the following restrictions&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:29.07pt">Neither (i)&#160;the Shares or any interest in them, (ii)&#160;the right to vote the Shares, (iii)&#160;the right to receive dividends on the Shares, or (iv)&#160;any other rights under this Agreement may be sold, transferred, donated, exchanged, pledged, hypothecated, assigned, or otherwise transferred, alienated or encumbered, by operation of law or otherwise, until (and then only to the extent of) </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the Shares are delivered to you or, in the event of your death, your Designated Beneficiary or Beneficiaries or testamentary transferee or transferees.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">You shall have, with respect to the Time-Based Restricted Shares, all of the rights of a holder of Shares, including the right to vote such Shares and to earn any cash dividends thereon, except as otherwise provided in the Plan.  Additional Shares of Cass common stock resulting from adjustments under Section&#160;XII of the Plan with respect to Shares subject to this Agreement shall be treated as additional Shares subject to the same restrictions and other terms of this Award Agreement.  Cash dividends accrued on Unvested Shares shall be retained by Cass until the underlying Shares have vested and restrictions lifted and shall be payable subject to fulfillment of the terms and conditions of this Agreement. Such dividends are taxable to you as compensation income, and not dividend income, and are deductible by Cass or its Subsidiaries for income tax purposes as compensation income.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:29.07pt">You shall have, with respect to the Performance-Based Shares, none of the rights of a holder of Shares, including the right to vote such Shares and to earn any cash dividends thereon, until such shares have vested and restrictions lifted.  Additional Shares of Cass common stock resulting from adjustments under Section&#160;XII of the Plan with respect to Shares subject to this Agreement shall be treated as additional Shares subject to the same restrictions and other terms of this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">During your lifetime, Shares shall only be delivered to you.  Any Shares transferred in accordance with this Agreement shall continue to be subject to the terms and conditions of this Agreement.  Any transfer permitted under this Agreement shall be promptly reported in writing to Cass&#8217;s Secretary.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:29.07pt">You may designate a beneficiary or beneficiaries (&#8220;Designated Beneficiary or Beneficiaries&#8221;) on the Designated Beneficiary form attached to this Agreement to receive Shares which vest on your death.  If you do not complete the Beneficiary Designation form or if, after your death, your Designated Beneficiary or Beneficiaries has or have died or cannot be located, Shares which become vested on your death shall be transferred in accordance with your will or, if you have no will, in accordance with the terms of the Plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt">Effect of Other Causes of Termination of Employment. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If your employment or service with Cass or any of its Subsidiaries terminates, as described in this Section&#160;7, prior to the vesting of Shares in accordance with Section&#160;2, you shall forfeit all such Unvested Shares&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:29.07pt">You voluntarily or involuntarily terminate employment without eligibility for Normal Retirement, as described in Section&#160;9 of this Award Agreement.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">Your employment or service by a Subsidiary of Cass shall be considered terminated on the date that the company for which you are employed or serve is no longer a Subsidiary of Cass, for reasons other than a Change in Control.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:29.07pt">Notwithstanding anything in this Award Agreement to the contrary, if your employment or service with Cass or a Subsidiary is Terminated for Cause, you shall forfeit all Shares for no consideration, including any Shares that have vested in accordance with Section 2.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt">Transfer of Employment&#59; Leave of Absence.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  A transfer of your employment from Cass to a Subsidiary or vice versa, or from one Subsidiary to another, without an intervening period, shall not be deemed a termination of employment.  If you are granted an authorized leave of absence, you shall be deemed to have remained in the employ or service of the company by which you are employed or of which you serve as a director during such leave of absence.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:28.5pt">Normal Retirement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Provided you complete one of service after the Date of Grant under this Award Agreement or the Committee waives this one-year service requirement consistent with the limitations set forth in Section 5.4 of the Plan, you shall be eligible for normal retirement upon your voluntary resignation after reaching age 65 with a minimum of 5 years of service (&#8220;Normal Retirement&#8221;).  Upon satisfying the age and service conditions for Normal Retirement, all Shares granted in this Award Agreement shall no longer be subject to forfeiture, though such Shares shall not become fully transferrable until the Vesting </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date at the end of the applicable Restriction Period or Performance Period described in Section&#160;2 of this Award Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Tax Matters.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:29.07pt">Federal Income tax withholding (and state and local income tax withholding, if applicable) may be required with respect to the taxation of income realized when restrictions are removed from the Shares or in the event you make the Section 83(b) election described in Section&#160;22.  You agree to deliver to Cass only the amounts the Committee determines should be withheld, provided, however, that you may pay a portion or all of such withholding taxes by electing to have (i)&#160;Cass withhold a portion of the Shares that would otherwise be delivered to you or (ii)&#160;you can deliver to Cass Shares that you have owned for at least six months, in either case, having a Fair Market Value (as of the date that the amount of taxes is to be withheld) in the sum of the amount to be withheld plus reasonable expenses of selling such Shares, and provided further that your election shall be irrevocable and subject to the approval of the Committee.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">You should consult with your tax advisor regarding the tax consequences of receiving shares and making the Section 83(b) election described in Section&#160;22.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Employment and Service.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Nothing contained in this Award Agreement or the Plan shall confer any right to continue in the employ or other service of Cass or any of its Subsidiaries or limit in any way the right of Cass or a Subsidiary to change your compensation or other benefits or to terminate your employment or other service with or without Cause.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Listing&#58;  Securities Considerations.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Despite anything else in this Award Agreement, if at any time the Board determines, in its sole discretion, the listing, registration or qualification (or an updating of any such document) of the Shares issuable under this Agreement is necessary on any securities exchange or under any federal or state securities or blue sky law, or that the consent or approval of any governmental regulatory body is necessary or desirable as a condition of, or in connection with the issuance of the Shares, or the removal of any restrictions imposed on such Shares, such Shares shall not be issued, in whole or in part, or the restrictions on the Shares removed, unless such listing, registration, qualifications, consent or approval shall have been effected or obtained free of any conditions not acceptable to Cass.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Clawback Policy.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Notwithstanding any provision to the contrary, in the event Cass materially restates its financial statements, the Compensation Committee shall have the discretion to rescind, revoke, adjust or otherwise modify the award.  Such action will be taken consistent with the Compensation Committee&#8217;s governing Clawback Policy, a copy of which is available from the Secretary of Cass upon request.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Binding Effect.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  This Agreement shall inure to the benefit of and be binding on the parties to this Agreement and their respective heirs, executors, administrators, legal representatives and successors.  Without limiting the generality of the foregoing, whenever the term &#8220;you&#8221; is used in any provision of this Agreement under circumstances where the provision appropriately applies to the heirs, executors, administrators, or legal representatives to whom Shares may be transferred by the Beneficiary Designation, will or the laws of descent and distribution, the term &#8220;you&#8221; shall be deemed to include such person or persons.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Plan Provisions Govern.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:29.07pt">This award is subject to the terms, conditions, restrictions and other provisions of the Plan as if all those provisions were set forth in their entirety in this Award Agreement.  If any provision of this Award Agreement conflicts with a provision of the Plan, the Plan provision shall control.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">You acknowledge that a copy of the Plan and a prospectus summarizing the Plan was distributed or made available to you and that you were advised to review that material before entering into this Award Agreement.  You waive the right to claim that the provisions of the Plan are not binding on you and your heirs, executors, administrators, legal representatives and successors.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:29.07pt">Capitalized terms used but not defined in this Award Agreement have the meanings given those terms in the Plan.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">By your signature below, you represent that you are familiar with the terms and provisions of the Plan, and hereby accept this Award Agreement subject to all of the terms and provisions of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan.  You have reviewed the Plan and this Award Agreement in their entirety and fully understand all provisions of the Plan and this Award Agreement.  You agree to accept as binding, conclusive and final all decisions or interpretations of the Committee on any questions arising under the Plan or this Award Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Governing Law and Venue.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  This Award Agreement shall be governed by and construed in accordance with the laws of the State of Missouri despite any laws of that state that would apply the laws of a different state.  In the event of litigation arising in connection with this Award Agreement and&#47;or the Plan, the parties hereto agree to submit to the jurisdiction of state and Federal courts located in Missouri.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Severability.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  If any term or provision of this Award Agreement, or the application of this Award Agreement to any person or circumstance, shall at any time or to any extent be invalid, illegal or unenforceable in any respect as written, both parties intend for any court construing this Award Agreement to modify or limit that provision so as to render it valid and enforceable to the fullest extent allowed by law.  Any provision that is not susceptible of reformation shall be ignored so as to not affect any other term or provision of this Award Agreement, and the remainder of this Award Agreement, or the application of that term or provision to persons of circumstances other than those as to which it is held invalid, illegal or unenforceable, shall not be affected thereby and each term and provision of this Award Agreement shall be valid and enforceable to the fullest extent permitted by law.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Entire Agreement&#59; Modification.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  The Plan and this Award Agreement contain the entire agreement between the parties with respect to the subject matter contained in this Award Agreement and it may not be modified, except as provided in the Plan, as it may be amended from time to time in the manner provided in the Plan, or in this Award Agreement, as it may be amended from time to time by a written document signed by each of the parties to this Award Agreement.  Any oral or written agreements, representations, warranties, written inducements, or other communications with respect to the subject matter contained in this Award Agreement made before the signing of this Award Agreement shall be void and ineffective for all purposes.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Counterparts.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  This Award Agreement may be executed simultaneously in two or more counterparts, each of which shall constitute an original, but all of which taken together shall constitute one and the same Award Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Descriptive Headings.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  The descriptive headings of this Award Agreement are inserted for convenience only and do not constitute a part of this Award Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Notices&#59; Electronic Delivery.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  All notices, demands or other communications to be given or delivered under or by reason of the provisions of this Award Agreement shall be in writing and shall be deemed to have been given when delivered personally&#59; mailed by certified or registered mail, return receipt requested and postage prepaid&#59; delivered by a nationally recognized overnight delivery service or sent by facsimile and confirmed by first class mail, to the recipient.  Such notices, demands and other communications shall be sent to the parties at the addresses indicated below&#58;</font></div><div style="margin-bottom:12pt;padding-left:180pt;text-indent:-144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:137.07pt">If to you&#58;&#160;&#160;&#160;&#160;_____________________<br>_____________________<br>_____________________</font></div><div style="margin-bottom:12pt;padding-left:180pt;text-indent:-144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:136.5pt">If to the Company&#58;&#160;&#160;&#160;&#160;Secretary<br>Cass Information Systems, Inc.<br>12444 Powerscourt Drive, Suite 550<br>St. Louis, Missouri 63131</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">or to such other address or to the attention of such other party as the recipient party has specified by prior written notice to the sending party.  You agree during the term of this Award Agreement to keep Cass informed of your current mailing address and of receiving written notice from Cass in accordance with this Section&#160;21.  In lieu of receiving documents in paper format, you agree, to the fullest extent permitted by law, to accept electronic delivery of any documents that may be required to be delivered to you (including, but not limited to, prospectuses, prospectus supplements, grant or award notifications and agreements, account statements, annual and quarterly reports, and all other forms of communications) in connection with this and any other award made or offered by Cass.  Electronic delivery may be via electronic mail system or by reference to a location on a Cass intranet to which you have access.  You hereby consent to any and all procedures Cass has established or may establish for an electronic signature system for delivery </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and acceptance of any such documents that may be required to be delivered to you, and agree that your electronic signature is the same as, and shall have the same force and effect as, your manual signature.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Section&#160;83(b) Election.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  In the event you make an election under Section&#160;83(b) of the Internal Revenue Code of 1986, as amended, with respect to the Shares, the parties hereto shall cooperate to insure such election is effective.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Authority to Receive Payments.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Any amount payable to or for the benefit of a minor, an incompetent person or other person incapable of receiving such payment shall be deemed paid when paid to the conservator of such person&#8217;s estate or to the party providing or reasonably appearing to provide for the care of such person, and such payment shall fully discharge Cass and Members of the Committee and the Board with respect thereto.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.5pt">Data Privacy.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  By executing this Award Agreement and participating in the Plan, you hereby explicitly and unambiguously consent to the collection, use, processing and transfer, in electronic or other form, of personal data by and among, as applicable, your employer, administrative agents and Cass and other subsidiaries for the exclusive purpose of implementing, administering and managing your participation in the Plan.  You understand that administrative agents, Cass, your employer and other subsidiaries may hold certain personal information about you, including your name, home address and telephone number, date of birth, social security number or other identification number, salary&#47;compensation, nationality, job title, any stock or directorships held in Cass, details of shares awarded, canceled, purchased or outstanding in your favor, for the purpose of managing and administering the Plan.  You further understand that some or all related data may be transferred to any third parties assisting Cass in the implementation, administration and management of the Plan.  You understand that these recipients may be located in your country of residence, or elsewhere, and that the recipient&#8217;s country may have different data privacy laws and protections than your country of residence.  You authorize the recipients to receive, possess, use, retain and transfer related data, in electronic or other form, for the purposes of implementing, administering and managing your participation in the Plan.  You understand that withdrawing your consent may affect your ability to participate in the Plan.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#91;Signature Page Follows&#93;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In Witness Whereof, the parties have caused this Agreement to be signed and delivered as of the day and year first above written.</font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.820%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.980%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CASS INFORMATION SYSTEMS, INC.</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PARTICIPANT</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Signature</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Signature</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;______&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;8</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>cass-20230418.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:0ddd94d8-9c78-4f2d-9ad0-68381cce4597,g:adb5d3f7-7c58-4aa6-b481-5b41f111169d-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cass="http://www.cassinfo.com/20230418" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cassinfo.com/20230418">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cass-20230418_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cass-20230418_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.cassinfo.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>cass-20230418_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:0ddd94d8-9c78-4f2d-9ad0-68381cce4597,g:adb5d3f7-7c58-4aa6-b481-5b41f111169d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_PreCommencementTenderOffer_1db7ad1e-5b7e-4d81-aa3d-969eca9dbbbb_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_0428394b-c41a-408f-8234-a1bcef3bf8e7_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_a6a9f91b-be24-4792-80fb-82522d1475ab_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_8c55e2de-6f3c-494b-99d7-a99e70510b07_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_6a03618a-f238-4e07-88f5-4b571dae6251_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_d78c5162-49f0-4265-99ac-55231191f65d_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_6a8ee6a3-3b66-423c-9cf2-041e2acc0d13_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_d9d288a7-8591-4163-98c6-879a87821d37_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_68123e8f-fb40-4aed-b4e6-c7daeafd677d_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_368138fd-488a-457b-89aa-b340b76d387c_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_43631692-8a84-4522-909e-11f97b6ee706_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_014bf6ab-2a82-49be-93cb-d9b15db7a50a_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_1e04c74a-d629-4cb6-a859-f8885d1609c7_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_0227a900-940e-4c23-8950-937831c0a7e8_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_8bfb986d-3b7d-403d-97be-e6c5563e6cab_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_82e7cc46-afcc-496f-b6aa-fc007f6bfe0d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_edca7291-6e94-4ea4-94a3-56eda72f30a8_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_9fe8ee4e-df01-4008-9535-115c1540f851_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_a5dc049b-0950-44a0-b524-977b232911da_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_778af860-482b-49fd-9df2-a138c71375e3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_c42de5d4-d9cf-4ab3-9936-40482338e14f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_53b80464-b879-4180-a2b2-0e6b93b9e91d_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_c75c3519-c4be-40ea-a9c6-1e64733def94_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>cass-20230418_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:0ddd94d8-9c78-4f2d-9ad0-68381cce4597,g:adb5d3f7-7c58-4aa6-b481-5b41f111169d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cassinfo.com/role/Cover" xlink:type="simple" xlink:href="cass-20230418.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.cassinfo.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_5f803759-c15a-48b1-8a3f-0d1b3a559714" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_d76da690-c79e-4d2c-a1a8-8864b357dd26" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5f803759-c15a-48b1-8a3f-0d1b3a559714" xlink:to="loc_dei_DocumentType_d76da690-c79e-4d2c-a1a8-8864b357dd26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_baba43ca-3411-4ca7-82d2-02b37d8d342b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5f803759-c15a-48b1-8a3f-0d1b3a559714" xlink:to="loc_dei_DocumentPeriodEndDate_baba43ca-3411-4ca7-82d2-02b37d8d342b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_03676f08-9944-461d-9379-0637dfd8bf04" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5f803759-c15a-48b1-8a3f-0d1b3a559714" xlink:to="loc_dei_EntityRegistrantName_03676f08-9944-461d-9379-0637dfd8bf04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_89deaa99-2e76-4951-9e91-5cb0b9e81f14" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5f803759-c15a-48b1-8a3f-0d1b3a559714" xlink:to="loc_dei_EntityIncorporationStateCountryCode_89deaa99-2e76-4951-9e91-5cb0b9e81f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_81d825e7-a7df-4eaa-9e56-ceb353a1d2fb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5f803759-c15a-48b1-8a3f-0d1b3a559714" xlink:to="loc_dei_EntityFileNumber_81d825e7-a7df-4eaa-9e56-ceb353a1d2fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_2ede4e66-fbca-4284-ac87-513bf9138237" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5f803759-c15a-48b1-8a3f-0d1b3a559714" xlink:to="loc_dei_EntityTaxIdentificationNumber_2ede4e66-fbca-4284-ac87-513bf9138237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_f4d18792-68eb-4e22-a16a-cac630877eb5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5f803759-c15a-48b1-8a3f-0d1b3a559714" xlink:to="loc_dei_EntityAddressAddressLine1_f4d18792-68eb-4e22-a16a-cac630877eb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_9e2abcf3-ba32-44fe-9c69-0fe1b737000e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5f803759-c15a-48b1-8a3f-0d1b3a559714" xlink:to="loc_dei_EntityAddressAddressLine2_9e2abcf3-ba32-44fe-9c69-0fe1b737000e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_80d6866a-00a2-4eeb-996d-032fbea97d89" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5f803759-c15a-48b1-8a3f-0d1b3a559714" xlink:to="loc_dei_EntityAddressCityOrTown_80d6866a-00a2-4eeb-996d-032fbea97d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_a6c217e8-1f65-4976-a4af-cf36970db42a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5f803759-c15a-48b1-8a3f-0d1b3a559714" xlink:to="loc_dei_EntityAddressStateOrProvince_a6c217e8-1f65-4976-a4af-cf36970db42a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_253a162e-70e7-428a-959a-5523d2665afb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5f803759-c15a-48b1-8a3f-0d1b3a559714" xlink:to="loc_dei_EntityAddressPostalZipCode_253a162e-70e7-428a-959a-5523d2665afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_ac4beacd-a861-47b6-86ed-14ad2c080003" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5f803759-c15a-48b1-8a3f-0d1b3a559714" xlink:to="loc_dei_CityAreaCode_ac4beacd-a861-47b6-86ed-14ad2c080003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_ec3fcdc4-c044-4c08-8c82-040a9912fd28" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5f803759-c15a-48b1-8a3f-0d1b3a559714" xlink:to="loc_dei_LocalPhoneNumber_ec3fcdc4-c044-4c08-8c82-040a9912fd28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_de7242d6-93c4-4b4f-93c4-5e512b0df822" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5f803759-c15a-48b1-8a3f-0d1b3a559714" xlink:to="loc_dei_WrittenCommunications_de7242d6-93c4-4b4f-93c4-5e512b0df822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_77922919-fe88-42ab-9b0c-e5b40e8c72de" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5f803759-c15a-48b1-8a3f-0d1b3a559714" xlink:to="loc_dei_SolicitingMaterial_77922919-fe88-42ab-9b0c-e5b40e8c72de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_be932959-88a4-42a8-a732-3948a20b89a4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5f803759-c15a-48b1-8a3f-0d1b3a559714" xlink:to="loc_dei_PreCommencementTenderOffer_be932959-88a4-42a8-a732-3948a20b89a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_097cba7a-7f45-4e75-97bc-b7a5ecc0f706" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5f803759-c15a-48b1-8a3f-0d1b3a559714" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_097cba7a-7f45-4e75-97bc-b7a5ecc0f706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_28d4790f-d018-4208-9165-10e4d2c35514" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5f803759-c15a-48b1-8a3f-0d1b3a559714" xlink:to="loc_dei_Security12bTitle_28d4790f-d018-4208-9165-10e4d2c35514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_ed5fa067-0fb0-4c80-b9c0-9ab1479962cc" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5f803759-c15a-48b1-8a3f-0d1b3a559714" xlink:to="loc_dei_TradingSymbol_ed5fa067-0fb0-4c80-b9c0-9ab1479962cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_020107de-4819-4aa5-8be4-35ac5bc34b9b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5f803759-c15a-48b1-8a3f-0d1b3a559714" xlink:to="loc_dei_SecurityExchangeName_020107de-4819-4aa5-8be4-35ac5bc34b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_bfeae490-9e9f-4c9d-9629-a568e8d59460" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5f803759-c15a-48b1-8a3f-0d1b3a559714" xlink:to="loc_dei_EntityEmergingGrowthCompany_bfeae490-9e9f-4c9d-9629-a568e8d59460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_30281db9-7fb4-417d-8f16-9589e97f5269" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5f803759-c15a-48b1-8a3f-0d1b3a559714" xlink:to="loc_dei_EntityCentralIndexKey_30281db9-7fb4-417d-8f16-9589e97f5269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_e96890c3-4ebc-4eb9-a926-d95b8d10d212" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5f803759-c15a-48b1-8a3f-0d1b3a559714" xlink:to="loc_dei_AmendmentFlag_e96890c3-4ebc-4eb9-a926-d95b8d10d212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140245508802752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Apr. 18, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr. 18,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CASS INFORMATION SYSTEMS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">MO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-20827<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">43-1265338<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">12444 Powerscourt Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 550<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">St. Louis<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">63131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">314<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">506-5500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.50 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CASS<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000708781<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>cass-20230418_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cass-20230418.xsd" xlink:type="simple"/>
    <context id="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000708781</identifier>
        </entity>
        <period>
            <startDate>2023-04-18</startDate>
            <endDate>2023-04-18</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl80L2ZyYWc6NjRmNDEzZWQ3ZTdjNDY4ZGJhNTM5Y2EwOGYwNmJhMjkvdGFibGU6NjM5OGVhMzU4MDgzNDQwMmE5OWJhOWViNDMxNTFmMzcvdGFibGVyYW5nZTo2Mzk4ZWEzNTgwODM0NDAyYTk5YmE5ZWI0MzE1MWYzN18xLTEtMS0xLTQ5NDQw_f884b5f1-15a0-4826-8568-963e0267cfe1">0000708781</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl80L2ZyYWc6NjRmNDEzZWQ3ZTdjNDY4ZGJhNTM5Y2EwOGYwNmJhMjkvdGFibGU6NjM5OGVhMzU4MDgzNDQwMmE5OWJhOWViNDMxNTFmMzcvdGFibGVyYW5nZTo2Mzk4ZWEzNTgwODM0NDAyYTk5YmE5ZWI0MzE1MWYzN18yLTEtMS0xLTQ5NDQw_40e45d8d-feb0-4b4f-a7b9-45559235c79a">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGV4dHJlZ2lvbjo0NTQ4ZDI1MTQyY2U0NTI3OTYxNGMyZTg3NjkzZTQ4MV8xMjY2_61fb654d-816c-4c7d-bc75-eb8fce248a7e">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGV4dHJlZ2lvbjo0NTQ4ZDI1MTQyY2U0NTI3OTYxNGMyZTg3NjkzZTQ4MV8xMjY3_02c5647d-36a0-425a-b4b9-33c0445c8925">2023-04-18</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGV4dHJlZ2lvbjo0NTQ4ZDI1MTQyY2U0NTI3OTYxNGMyZTg3NjkzZTQ4MV8xMjY4_62afc22e-ce72-467d-b7c9-76ba3c764854">CASS INFORMATION SYSTEMS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGFibGU6NzcwYTU1YTJkNWZlNDhkMGI3ODkzZDY4MGZkMTkxMjgvdGFibGVyYW5nZTo3NzBhNTVhMmQ1ZmU0OGQwYjc4OTNkNjgwZmQxOTEyOF8wLTAtMS0xLTQ5NDQw_f8733ec8-4468-459a-85ab-17fea517e00a">MO</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGFibGU6NzcwYTU1YTJkNWZlNDhkMGI3ODkzZDY4MGZkMTkxMjgvdGFibGVyYW5nZTo3NzBhNTVhMmQ1ZmU0OGQwYjc4OTNkNjgwZmQxOTEyOF8wLTEtMS0xLTQ5NDQw_40412d78-65f2-4a71-bbc2-b9714760890b">000-20827</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGFibGU6NzcwYTU1YTJkNWZlNDhkMGI3ODkzZDY4MGZkMTkxMjgvdGFibGVyYW5nZTo3NzBhNTVhMmQ1ZmU0OGQwYjc4OTNkNjgwZmQxOTEyOF8wLTItMS0xLTQ5NDQw_3046d623-e747-4184-a608-f569f6a8dc85">43-1265338</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGFibGU6ZjQwMzVkMWVkMmE2NDRjOTg0OWJiYTZjMDQxMDZmMjYvdGFibGVyYW5nZTpmNDAzNWQxZWQyYTY0NGM5ODQ5YmJhNmMwNDEwNmYyNl8wLTAtMS0xLTQ5NDQwL3RleHRyZWdpb246MTkwNTRmYjUyZjg4NGE2ZmE1ODRhZDc0MTQ2YThmZjlfNA_0b152b85-639c-4950-9d51-84e91b2351e2">12444 Powerscourt Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGFibGU6ZjQwMzVkMWVkMmE2NDRjOTg0OWJiYTZjMDQxMDZmMjYvdGFibGVyYW5nZTpmNDAzNWQxZWQyYTY0NGM5ODQ5YmJhNmMwNDEwNmYyNl8wLTAtMS0xLTQ5NDQwL3RleHRyZWdpb246MTkwNTRmYjUyZjg4NGE2ZmE1ODRhZDc0MTQ2YThmZjlfOA_fd108b36-6aa5-4ce2-bccc-c27dc41e0999">Suite 550</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGFibGU6ZjQwMzVkMWVkMmE2NDRjOTg0OWJiYTZjMDQxMDZmMjYvdGFibGVyYW5nZTpmNDAzNWQxZWQyYTY0NGM5ODQ5YmJhNmMwNDEwNmYyNl8wLTAtMS0xLTQ5NDQwL3RleHRyZWdpb246MTkwNTRmYjUyZjg4NGE2ZmE1ODRhZDc0MTQ2YThmZjlfMTE_03d785a6-0c4f-4ac9-b7f8-dfbee96f4910">St. Louis</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGFibGU6ZjQwMzVkMWVkMmE2NDRjOTg0OWJiYTZjMDQxMDZmMjYvdGFibGVyYW5nZTpmNDAzNWQxZWQyYTY0NGM5ODQ5YmJhNmMwNDEwNmYyNl8wLTAtMS0xLTQ5NDQwL3RleHRyZWdpb246MTkwNTRmYjUyZjg4NGE2ZmE1ODRhZDc0MTQ2YThmZjlfMTU_386c5169-e3de-4797-b33d-3fd6e06d8880">MO</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGFibGU6ZjQwMzVkMWVkMmE2NDRjOTg0OWJiYTZjMDQxMDZmMjYvdGFibGVyYW5nZTpmNDAzNWQxZWQyYTY0NGM5ODQ5YmJhNmMwNDEwNmYyNl8wLTEtMS0xLTQ5NDQw_e5a7ff6f-cc24-40f1-be39-af7db4e619b3">63131</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGV4dHJlZ2lvbjo0NTQ4ZDI1MTQyY2U0NTI3OTYxNGMyZTg3NjkzZTQ4MV8xMjY5_077762aa-7fdb-4c92-8280-55c947655c72">314</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGV4dHJlZ2lvbjo0NTQ4ZDI1MTQyY2U0NTI3OTYxNGMyZTg3NjkzZTQ4MV8xMjcw_828c166b-33ef-4cbc-a4ce-39272cf8b24b">506-5500</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGFibGU6Mjg0YWMxMjAzM2JiNDY2YTk2YmI3NzZhMjJlYWY3MjQvdGFibGVyYW5nZToyODRhYzEyMDMzYmI0NjZhOTZiYjc3NmEyMmVhZjcyNF8wLTAtMS0xLTQ5NDQw_9ef52026-843b-4665-84c5-31093d267fdf">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGFibGU6Mjg0YWMxMjAzM2JiNDY2YTk2YmI3NzZhMjJlYWY3MjQvdGFibGVyYW5nZToyODRhYzEyMDMzYmI0NjZhOTZiYjc3NmEyMmVhZjcyNF8yLTAtMS0xLTQ5NDQw_4a4203b5-a806-4882-ba5e-a33d6f236630">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGFibGU6Mjg0YWMxMjAzM2JiNDY2YTk2YmI3NzZhMjJlYWY3MjQvdGFibGVyYW5nZToyODRhYzEyMDMzYmI0NjZhOTZiYjc3NmEyMmVhZjcyNF80LTAtMS0xLTQ5NDQw_5e669f6b-a4e2-4739-8cb9-f5b515162442">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGFibGU6Mjg0YWMxMjAzM2JiNDY2YTk2YmI3NzZhMjJlYWY3MjQvdGFibGVyYW5nZToyODRhYzEyMDMzYmI0NjZhOTZiYjc3NmEyMmVhZjcyNF82LTAtMS0xLTQ5NDQw_875cdc2e-009b-4c75-869d-ffb88ffcca4d">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGFibGU6MTUzNmE5NTg5OGU3NDM3NmFlNDdmYTcyNTIyNzM5MjYvdGFibGVyYW5nZToxNTM2YTk1ODk4ZTc0Mzc2YWU0N2ZhNzI1MjI3MzkyNl8xLTAtMS0xLTQ5NDQw_1acf3274-4e6e-46c9-8bb6-8c356edc44f3">Common Stock, par value $0.50 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGFibGU6MTUzNmE5NTg5OGU3NDM3NmFlNDdmYTcyNTIyNzM5MjYvdGFibGVyYW5nZToxNTM2YTk1ODk4ZTc0Mzc2YWU0N2ZhNzI1MjI3MzkyNl8xLTItMS0xLTQ5NDQw_31b4d533-cbc5-4246-bedf-323650142360">CASS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGFibGU6MTUzNmE5NTg5OGU3NDM3NmFlNDdmYTcyNTIyNzM5MjYvdGFibGVyYW5nZToxNTM2YTk1ODk4ZTc0Mzc2YWU0N2ZhNzI1MjI3MzkyNl8xLTQtMS0xLTQ5NDQw_50d5d141-bcb0-4990-9a59-86bcf2660e81">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="i12e2040fa7404982b330c46c128ce15d_D20230418-20230418"
      id="id3VybDovL2RvY3MudjEvZG9jOjhjNDcyYWFmYTQ3NTRlZGE5MjYwMGMzNGNjZjUzMTZiL3NlYzo4YzQ3MmFhZmE0NzU0ZWRhOTI2MDBjMzRjY2Y1MzE2Yl8xL2ZyYWc6NDU0OGQyNTE0MmNlNDUyNzk2MTRjMmU4NzY5M2U0ODEvdGV4dHJlZ2lvbjo0NTQ4ZDI1MTQyY2U0NTI3OTYxNGMyZTg3NjkzZTQ4MV8xMjcx_2e7ddc56-aac5-4502-b397-dde1857c7342">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( %9TE58'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " !6=)56M]M"0>X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+/
M2L0P$(=?17)OI_\0"=U<5CPI""XHWL)D=C?8M"$9:??M3>MN%]$'\)B97[[Y
M!J9%+W$(]!P&3X$MQ9O)=7V4Z#?BR.PE0,0C.1WSE.A3<S\$ISD]PP&\Q@]]
M(*B*XA8<L3::-<S S*]$H5J#$@-I'L(9;W#%^\_0+3"#0!TYZCE"F9<@U#S1
MGZ:NA2M@AC$%%[\+9%;B4OT3NW1 G)-3M&MJ',=\K)=<VJ&$MZ?'EV7=S/:1
M=8^4?D4K^>1I(RZ37^OM_>Y!J*JHZJQHLJK<E7>R;F33O,^N/_RNPFXP=F__
ML?%%4+7PZR[4%U!+ P04    " !6=)56F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M %9TE5:C*9<%9@0  "L1   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MG9AK<^(V%(;_BL;M=-J9!%^X;@K,$))LF<V%C6EWVDX_"%N )K;D2G((_[Y'
MAMALUQS3?L&6\7EYI'/T2F*XE>I%;Q@SY"U-A!XY&V.R*]?5T8:E5+=DQ@1\
MLY(JI0:::NWJ3#$:%T%IX@:>UW-3RH4S'A;/YFH\E+E)N&!S172>IE3MKEDB
MMR/'=]X?///UQM@'[GB8T34+F?DUFRMHN:5*S%,F-)>"*+8:.1/_ZCKHVH#B
MC=\XV^JC>V*[LI3RQ39F\<CQ+!%+6&2L!(7+*YNR)+%*P/'W0=0I?],&'M^_
MJ]\5G8?.+*EF4YE\X;'9C)R!0V*VHGEBGN7V%W;H4 $8R407GV2[?[?3<4B4
M:R/30S 0I%SLK_3M,!#' =Z)@. 0$!3<^Q\J*&^HH>.ADENB[-N@9F^*KA;1
M ,>%S4IH%'S+(<Z,I_*5J:%K0,H^<*-#V/4^+#@1-LE4B_B#"Q)X0?OK<!<(
M2HR@Q @*O3:&0?Z<++51D*B_ZHCV"IUZ!5N]5SJC$1LY4)Z:J5?FC'_XSN]Y
M/R-\[9*OC:F/;V240RT:LMAEK X.#Q]<?D(@.B5$YSR(.5-<QN16Q 227LN#
M*Y7I:\I?MT3KHH*WPG"S(\]LS6T&@?&1IK5@N,YT$H9D]GCW]/PP6<R>'DGX
M>[BX?0@OX.&TA8#V2M#>.: S$4F5246M-5R0T, P$JG(5.;"J!U<XUIZ7/SA
M"2'LEX3]<PCO>,+(8YXNZZ<GKN%YWF7@#8(^PC,H>0;G\"SH&YG%4'U\Q:-B
MV! Z7+'3OO2#7K?='B!X'TJ\#^?@3>(89KV^>+\A]_ >>1*U6<05_:#3Z9"Y
MW#*E(YDK0VX4K!P(J^]5;NO]?]K%5M8Z,2X9YAQJM]OU,,"CY<#_3X!3VX*)
ML9!;40N'RX6F1>YESC4&5RT2/NKQW\"5TW:NY"L746VR&S31.>M7ZX./._R_
MT>92&YJ0/WAVTDL:%'MMO^UC;-6RX>-N7^1P GNVTRBX0-OO8"#5(N'C[GXO
M(QB3^48*S-H:1+I>[Q*J'2WW:C7P<<?^HK@Q3,# I&DN#L:F:ZEPH15--&H1
ME?W[N'>',N$1-URLR0.4M^(TJ>7!51IY*OOW<;>>*W89P? PF%_[+1 3,6S6
MGE:K$_G#]1K)*N?W<:/^AFRF=0YDC8"X;!-@4+E]@%OS@AM8Q.6*^,&/RY](
MR*(<ZFU7N[G%E6Q]PHH;&AF]7)",*O)*DYR1[[U6UR,9]%9OJ$*IJR4@P#U[
MH6ALJR_<I4M96WL- G83AY$<'0IP;WX?,'+[%FVH6+.3N\H&H<=)>#/YC#%5
M1A^<9?2W*5-K.TH?0<%LK(%D5-2G%A=L++?*YP/<I@]H4Y@*"GQV!K/@C7QB
M]5"X%&P@O;XWZ ^P%2BHC#_ /7L"TS,NINA=0M>U/+C R4%RCXZ^]F^$!VK3
MHDG"5B#DM?J@J_8G\WW#R*PX#2^E@;-U<;MA%/S"O@#?KZ0T[PU[P"[_'QG_
M U!+ P04    " !6=)56GZ ;\+$"  #B#   #0   'AL+W-T>6QE<RYX;6S=
M5VUKVS 0_BM"/V!N8FKBD1BV0&&PC4+S85^56'8$>O%DN7/ZZZ>S;"=I=67=
MA['-H<G=/;J[1W<GF:Y;=Y+\X<BY([V2NMW0HW/-^R1I#T>N6/O.-%Q[I#)6
M,>=56R=M8SDK6W!2,EG>W&2)8D+38JT[=:=<2PZFTVY#;VA2K"NCSY:4!H-?
MRA0GCTQNZ)9)L;=B6,N4D*=@7H+A8*2QQ'DJ?$,78&F? KP(&K <XRBAC05C
M$C*$[_VX_!DP::U7A90SP24-AF+=,.>XU7=>&18/QA<0&>7=J?$,:\M.B^4M
M/3L,/S[)WMB2VSG-@DZF8BUY!72LJ(_PZTR3 .B<45XH!:N-9@.'R6,4?-@#
ME_(!6OBMNHK=5R3TXE,);2"PU4GTA$8QA D*Q+^,%F)?A+W]K;"D$8_&?>S\
M;O2@?^^,X_>65Z(?]+Z:\V/1%WATUC3R]$&*6BL>]O[+"8LUF_S(T5CQY+/!
MI!R\@5M*'KEUXG!I^6%9L^.]FZ:IKW#.RW^0\Y^M<\TUMTQ>DO:C_S=7^2V,
MD_'T7!S1JP,Z6PE<A!OZ%>Y7>>9 ]IV03NA1.XJRY/K%.?7A'=O["_PJOE]?
M\HIUTNUF<$//\A=>BD[E\ZI[J,NXZBQ_AOMHD<VWL,\E=,E[7FY'U=;[021>
M\%G'!QR>(W?#$T<PGX#%$<"P/!@#S"=X87G^I_VLT/T$#..VBB(KU&>%^@2O
M&+(=/EB>N$_NG_A.\SQ-LPRKZ'8;9;#%ZI9E\!>/AG$##RP/9'I;K?%NXQ/R
M^AQ@/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q _G@>F*FX3YI"5S%N
MV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"IQ%', ;  4/2='@/
M/GL?)=-[*CG_5U/\!%!+ P04    " !6=)56EXJ[',     3 @  "P   %]R
M96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:
MI7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$
MVV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_
M,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH
M^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    ( %9TE5:JQ"(6,P$  "("
M   /    >&PO=V]R:V)O;VLN>&ULC5'1;L(P#/R5*A^P%K0A#5%>0-N0I@V-
MB??0NM0BB2O'A8VOG]NJ&M)>]I3<V;K<7187XM.!Z)1\>1=B;FJ19IZFL:C!
MVWA'#02=5,3>BD(^IK%AL&6L <2[=)IEL]1;#&:Y&+6VG-X"$B@$*2C9$7N$
M2_R==S Y8\0#.I3OW/1W!R;Q&-#C%<K<9":)-5U>B/%*0:S;%4S.Y68R#/;
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M>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ 5G255F60>9(9 0  SP,  !,
M  !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F&V +77 !
M8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5!TYB
M'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY&TWP39G
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M+GAM;%!+ 0(4 Q0    ( %9TE5:WVT)![@   "L"   1              "
M :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( %9TE5:97)PC$ 8
M )PG   3              "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L!
M A0#%     @ 5G255J,IEP5F!   *Q$  !@              ("!#0@  'AL
M+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( %9TE5:?H!OPL0(
M .(,   -              "  :D,  !X;"]S='EL97,N>&UL4$L! A0#%
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K  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  /T3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="cass-20230418.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassinfo.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="cass-20230418.htm">cass-20230418.htm</File>
    <File>cass-20230418.xsd</File>
    <File>cass-20230418_lab.xml</File>
    <File>cass-20230418_pre.xml</File>
    <File>exhibit101-2023omnibusplan.htm</File>
    <File>exhibit102-restrictedstock.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cass-20230418.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2021": 23
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "cass-20230418.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cass-20230418_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cass-20230418_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cass-20230418.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "cass",
   "nsuri": "http://www.cassinfo.com/20230418",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cass-20230418.htm",
      "contextRef": "i12e2040fa7404982b330c46c128ce15d_D20230418-20230418",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.cassinfo.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cass-20230418.htm",
      "contextRef": "i12e2040fa7404982b330c46c128ce15d_D20230418-20230418",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cassinfo.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cassinfo.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cassinfo.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cassinfo.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cassinfo.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cassinfo.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cassinfo.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cassinfo.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cassinfo.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cassinfo.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cassinfo.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cassinfo.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cassinfo.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cassinfo.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cassinfo.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cassinfo.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cassinfo.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cassinfo.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cassinfo.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cassinfo.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cassinfo.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cassinfo.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cassinfo.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0000708781-23-000017-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000708781-23-000017-xbrl.zip
M4$L#!!0    ( %9TE5;Z['SFER   )41 0 1    8V%S<RTR,#(S,#0Q."YH
M=&WM76MSVLR2_GY^Q2QG]VQ2A;#N%YQXBQCLE[Q!Q#:.#WQ)C:01R!821Q+&
M^-=OSTCBCH,3W\"X*K%!H[ET]_0\W3TS_>G_[OH^NB51[(7!YX)0X@OH_XX^
M_1?'_?O+^3=4#>UAGP0).HX(3HB#1E[20U<.B6^0&X5]=!5&-]XMYCCVSG$X
M&$=>MY<@D1>EA8=1F7<<QY =G3-L3>=D5W0X SL\I^J2+M@VD15#*W;+V+$4
M1W(U3K,5*(:QREFR+G"*)0NN #^JX12=LF[+FHBQBV5-D8F##5'E>5N2;=M5
M)$&U:+.]!$8'(PSBSX5>D@S*!P>CT:@TDDIAU#T0#,,XN*-E"FFALD.\2<$[
M*_)+,;%+W?#V !X<P)B$O*!WE\S5R K3.KW ]P)"B7>01#B(W3#JXP2(2U_G
M.5[D!'&F$@X:F*LH;_"A>@2%XW5.FG3F#HK>K!\@?3IM<G6WH5)IILU)S;&W
MJEZ1YX6#?S>^7=@]TL><%\0)#FR2O[74G9EF>.F /K9P/"E.GWH/E)^KONSC
MH/NY0 +N\J( #";8.?K4)PE&]'V._&?HW7XN'(=! F++M<8#>,U./WTN).0N
M.6#\/CCZQS_^\2GQ$I\<V3B..2JPO"SHGP[2+S\=I%5;H3,^^N1XMRA.QC[Y
M7'"\>.#C<3D( P(=\.[*M"")TC\]QR$!^Q.>FS!W(L].V[]+SHG[N> )(A%Y
MF7>Q)O.RH8N6)/&VK-J"J-M$4)R?U;PKDSX54(#[M&GBE6L!]&]\#,.)L%\/
M''+W-QD7D.= U8[T8VQ5P]MOXOEM6VH,G>O:;>?4N&Y>]Z[-JCUN7YWTVZTS
MR6R=^YW3FM*X;H\:IXU[\]2\[EQ?WC=:'>^;9/KM^U!NWY])C?Y)K].O\>;]
M)=^Y.N\U6W6Q4?URW;@_OVZ+;:%Q7Q/;OLY_$SM0MZV:U^=]LUJ[[UR=29V6
M VVVY<[IUY[9:BAML39JGK9'9O]KKW%]<^N<GGC6Z26\TU":IS]ZC?M+N5'M
MWIO5LU&C7U.:5U][S:L?GEEMW)FMDW[CWL[>^0%M*4&G%8J-^QNY<U6[-UO=
M4;/:X,UJ9=QNW2AM>+]S5>>A?T+CJGUO"OK=MU8M:5SP\/M,H6W\='5=MA17
MX 0%\YRLBRJG*RKH)E4BO*AJMDN$PA$//QJO:[KPZ6".J<_)XPJH7(>JW1,?
M=PLHG?I0[5U2=KT[XG N]NGTV3/]8::/EY@N\[#(.#I0D%C =$MV.:Q9!B<K
MBF*(DF)K!BX<G52^7=26^'TP/[\CXI*(@%J*5Z@EJN+*,=..(!&(J>!R LKH
M<R'V^@.?ZC+V72^B C.G@4IWL0-5',S7D;8_;33K0QP.(_:)*=%R)H6I9/R.
M%.85$:9F\D^>0S^['HD0ZQ!9N60=U_^>GS"++Q_E7\W7/@#ZAD[^"71]E%0!
M;!S13G&\S%&EO/ALTDUG3='\2?XY;^1@CE Y52=D/)C1YP>@]5/5S\CY*[SQ
M4RC,OI,M%WTOX'J$8J*RK R2PY'G)+VRP//_4V#ECC[% PP2944'\';Z=UK)
MI*JC3PFV?)+7:(41=(^S0]_'@YB4\S\.\Y4I7<8Y]M)A'T==Z((5)DG8+],>
M -A+/!O['/:];E"F9,@>3SM7XM,.)D"&Q,E;SAZ7V*.#Q%E^9N@E@U__F"\)
MDV<'K.XH+Y#12!HD!?8>C(H2XW-!*BP,/!L*E$1..*2$^2?T]G" '<<+NF4>
M":R.:2,'C!(K>,.&GE+!!I$D42'E1OX<^A!&95H[;< %D0'-V_?\<?E_6UX?
M)KY)1N@\[./@?XLQ8#0 <Y'GI@5C[YZ4!1WHS3Z.TN%I4 ]C3C9<0:3$NC3K
MK5H57;0JK=K%O!"\P=Y>U(XOS^NM>NT"5<PJJOW[^*^*>5I#Q\U&HWYQ46^:
MKS@$<:,A7.&X![*2A$$154O')3!7%-E8V^UL#B7AH*Q"_2\_"GGE*'ZN_-ED
M%*R!MR)/)\WSQK_^*:C\X3-"JMR030V"UP1.=Q/@5+WDFZ=G8[-5XQM]TX?/
M8_/^1FRTSJ\;_4O9O&\K#1'*5&L @G[(SE]?_8[HWUK7(6^VSN1.M2XT6F?C
M-I0Q6W6IV6K?F:>-<:?5E<SKF_L.E&G\T.^@W^)/57 M59$=3A=4FY-MS>$L
M6U,X8NFN3419QQI8,SKW]S+LV4^*5]!0H&+/:V8+G=>^-\];;UZA?K\\O[BL
M0'];303K0PL6 21(J'F.!.6#\_'-][]Y@EI_U=#,TC99UBK'+02/!4.2MTZ*
M* )&H8O.R2",$O3!R3X3#!B8Q DBM]2Y%[''Q/E8?C$]_)W!\5H*TN=-7-I)
MK@]M]NAKG(/'W!@ZS)'@_2ENZ2<OVHHJ@[J65.JF$!7,63)8K))D\[*LV+HA
M*H6CRB#R?"3H1>9XW>OPYQV&*&\T^Y[="WA.NEY,O<.)"4_>W^R0?ZHB=FU1
M))Q--)&350IK--O@--7"DJVILJ[(L)A6+BY0W:1 L\*6IHOV1:O6N"C"E\>E
MC6?+\T\/?B.Y^E"[PW;"I($J\V@B!0C'*!X0FSI;'.0%R$MB9/<PZ/9H_1J\
MDTJ@L$5.$TDLB9*TD=/DK50K/\;%L\Z?DWMLQ,$=]=DL2]XBU5."O_RLXU]$
MF]<#.XP B+$HWT4"*.@X' 9)-#X.G7F(1(.&U!>:D$$4WM)ZMA0;9=& >WO4
M;ET*[=;7&_.J ^_T;AJGH/FKH.VK;;EQVKEIM&Y XW<7HP&2>?^E9[9^]!K]
M,Z'39VV/VM>VW&R9-^9U=]3IG]TU6[5Q\T0??6M5%D- FB016^=D687_% -S
MNH(M3M!<@A5!(SR/"T<-+Z;N86_M.I%-@[V$_TK"3SR?0.T6K"E[:?VUM"[%
MKF1!=#2=4Q47L [6!,ZR;)&S#$V0-977#=YB\1?@@"YJ>W']4W%MX;MZ%KNR
MF5+>R^[&LEN?EUV@L.JHHL013=8XH+;,89!8SE54PU6Q[M@Z6+&RQ FBJDB2
M_J#P/C6L ,SXU"+\2\\WD^ /;)5'883"I$<B= VK3.QX-I4U0/8L)NC-H@)6
M-.KBP+MGGS\^QZ1^/7(<A_T^++8P,#9TNER@=,[MV$#KI?/210G5^@,_').(
MC79>U2 S+'U<EOJUH<PM-G_DS6/&SU3M[RL4G[A+Q)DLBC/LR:K@V.;(,B>4
MI)42NJLK:<5Q(A+'V:]OT %ABU?1SO79J''_XZ9Q!?_Z-=&LGE\W6UV^>?75
M:[<ZUXWJV5VCVNE#7Q=6T4'?K%;NS:NSN\[5V;C=:O/F:4-I5L^4=O]KS^PW
M1F:U-C+[[;'I+]LKWZ1SG_QU/NY<.0-+E%58J4= EW[[^G+<N>[*YFE-A+$+
MS>IYKU.U^4;K3&RW>OW.M>^:E9^\)2BBI2N<*ADV)QL*SQF.(G"Z3 S!$B5%
M(&+A2!!E64;?PQ&)8AO,G@15(^^6+"[(Q6>/%*R3''$O.2\J.<W*3]<1>-V2
M5$[%6.%DFX#18=LV9XN:8\L"X0W#*!Q=##T ,XK";^Q0W6M%*M3'\&<S:H6C
M;?;A;*-D-UJUG[P$%K6"50[8YX)1;1N<I;DZY[@6(8;JRH; @V@G)?0M''KQ
M*ZM!9B\TH^]1>.NQ#?&[ZQ3<3H&Z_"GIJJT(JL$1R2&<K!D:!QQW.,EU5,*K
MCJ[K_ 8^Q70'Z-Y5\[CY\3V$">!WO$'J,M\+_R^%?\''2!2LN:[J<K8MRAQP
M1> L(AD<=C7'DHDJ&)94.%(E05H^#[&;+II,LFB@=1"!TO4&V$?DCMC#!& Q
M? T6.XEWS#\!,PC1*?0''HBW ./2:/DS*A\*W2H1P5NK;OYH^X7RD]<T314Q
MYC37L< P,$1.%W6>4Q3;D#45?FE@4DJ"O*@L/CX[;OH6PD3ZW@N#;8XX_0E[
M[-%/X(4MJ*K%21(!<&M;-H?!>N,D0]1$V]4!WUB%(X57@6'\YF;;L\_LS?:-
M?YAN?_K7/W51T YCE!"?#"C34<"X7D2@LOTAU;L(PT0%$9O5:N]B*TPZ#"^@
M_N6R*)84YAY^7E6\>AS'/6+?H*1'$!Z D0+K*0U_6.$=LH@?CI#GLH<G8-2D
M^D'G_D[_<#V?LM"+@9\)@:$X* E1[/6'?H(#$@YC?XQBG'BQ.V9U9"^$%G O
M"YVDE<_LEAI"/1'"P3A_YH8^=(.^1TTHCP8BXO+&9,Z]&=0G7!:U!<)S])MM
M<LM+)4$6G]PK;\@E5=%?P2N?@JG)@;L-1/\*:J<MQ'\F],^XQEU%7@*S@8;-
MAD$6.(K?Z'GA/[*'&M==OGW5@%6M<M\0OWIF%6INW8CM?ETR[SN]QO57OWT%
MH[D^6XQ;CZFAWKZOC1O5QCV4YV$4T,>.U[ZV);,/W_=_]#K7]MA<M4/((*X"
ME%<Y798 X*BJ G_9"B<)O"$YH@JXQRT<_>N?AB;+A\]AS#^-*#^I%L^D#@8R
M*W9H,(SB(56KH)C/AZ#C9%')5"S5K1=@,<&+'O2C8B>E%;19?2#4>.! Z,HC
MGX\HNM<PO](P%Z'OV<"UH-N I1K6:W^O7GY;O8R7U(N,99&7+(7#.H!P6==%
MSL(*X; D.:HK2JHJ\:^G7A;#- \#F]=015/Q1/U,/I?T4 H@!1ES@IC^/55*
MM3N[AX,NV:ND[5%)WR-" 0^]!(,=Z*760-1T76KB[U73;ZHF?DDU*42E6_,L
M#LM$Y&1-,CC=M@S.52Q%4 15E&5QKYK6SP 04\Z>D=-4]?P",^6ZRN'$#];'
MO;;:.6U5C^,AB?8ZZRETEKBDLW1-L1U;)!S/&]0=K8&UIAI 4-?2==>U;2P[
M3ZZS$/TMZBO$>TD5O4" YP6TDT0X^8.]H7;ZG9VKKX(DI^9IZB$D$7'F*  E
M*%DR(E#]G+L-8< ;>PFWR@,HE SI]S;F/OQ,YM6G/Y8HE#1M,\?BV^BL_MQ[
MDU]R'\AF<>46O5DSO7_"[B';QW'\B+CY(T#*=E CPK2S;//_Q;AOA?X[)H:9
M'69GDD&RI821)@S0J.?!MU.]_)BM)IF"9?H7%NLX]#UG_L*XU]R/\?K[I[*%
M;RR(%IN>VXP[6Y?W@!$5L]55FJ>7DEEM &8\@7<=Z"M@QE8=ZF@HR[NFPCNS
MU: 856A6;^1.R^8;][;8OKKD3;'3,^_K0N.Z+C7N;^BNJ;LEW"E@VY5$3>9D
MH@(X4FVPE2U+!8-94E3BV++L2H4C:@> ,%\DH7U31 ,<H5OL#PGZ;[ZD\&A
M[];LX6AII_W3*H7]='AX.F1*.=7'^[FPP5Q8/.DI6+*C2!)G6[;"R:*L<A9Q
M7$X2)57A!1E^\>F-+'M!?PMZ/S?;TAN$%O>3TY5XZ[>2O]Q<.%OPH?*.X@BR
MP%DVO6W:,'C.P HL#JIENZ*J\D07*/2)'?P?=.J'%O;!S/3!T$0-'-V0Y-=[
M;-^X65T/'.I.(,@:(YOM_H%^W0"@(^S \\*&'"]&T$4"8^W2D$XW"D=)C\:9
M!W23#HZ10UQH@EUME(:8>24WPN?CR_1;P9 D](':Z]HAR']I4MACER(-Z*5(
M]$#UC&M#M+@L1K1<ZZQ_(ZM>3LOF;<A@MRW4,--4Z7'[M5+5PTY&O1+O:FOX
MD(]C9WRTZ1&"?+BG;+3'Z6!WRSW[1]M)[WZ*1',<6U$YC.G2KO B9TF&QCD.
M$71%LS5IXY#0VU-4[@.JA^XB7:G'O*4]A3W04DR#@Y8*0N8X',:$E0)QS78N
MTGPN'MN4F-Y*3X6,M>6/:>,LQPZ=:0&,#9Y$Y-:+X3W0?3BP:8P;VS:]&HH6
MIJE1'!PY<;IGT7G0:RE]P!.OY9R_]I4F]416=L]YNETWX<]F*!B$J7"6(^)C
M>LAE*6?!M!NL?7[Z"K8 : ^3]:^LVU*]/@'"8[,P:(7\G5XTM1NZA+,B@F\X
M[$*C9>R/\#@N'#QUJH85P[P>QHGGCE_I]$L](=E>:J7$BZ5'3O,G5;%I-Y;_
M?YD^K;D@F0QPE PCYGNL>A%HRS"*J=(]!MV  6<VV0&O*#Y$-9_D-_-,BQZB
MRF 0>D'"LJ3!D^7W*)0@08RA^!A5HH@J75HZ7E7\-XXF/+N L1K+7@+-V1OP
MN4+W]M_"*I4M-"P57+,?>-8P3KU?L+@YZ#N)&+8*;#(E$27O=Q\'FYP]F1_W
MJFGYX'MSX5E)?37D44FF5*H$P1 (UR"$K>U P OJ$NR%/JC[&'V@!>E9%Y$_
MG"_*OA0.V>)^C.,8U8-)PCAT,8Y!"\1%^-(NS562H=S\[2+J$=]!\,K\?=(;
M-%QD@YBICQW'B6=[S\Y\W%+\0TL^W,G?D9FY7LY50)_F'2VAUJ),LI='F"(H
M0%KI69))9ZWQRI%]"0%SS2N-V>;9XRE3 G1"K&B(00$(:DK3(AH.X'MXF87A
MG;E#*G-C8[=B)0DA^5-6>1'%0^N:N@KH09@IG;.>8W_=0"E"M0@!L!M3-.#%
MO?0P340 ,MFD2'N+*9BD-PFS,ZX6CKVXN G;6.(RJ([RZIRPRPB<Q[*QF(5[
M'F#(O%A!A;"DP^+-6@-=2M%QY+#:&92FMR#3$O&,9&LI%]8;Y;NG:%:+PX"2
MCA((GG:9"0-2%C-6A8-T'\@'>M=$P$1A_@$E/9AX_P%]D%XY/?<8=$+ZF;*.
M@-W"6,P\&B O$8@'V(5)_M;R-V@8>+3D ,P4@)EY,=JHC>,>1U-(.K3_$UG"
M(VH(K9WAGN^#Y"/L@*SD.SQFIO<O)AP%!5":TLH!"Z\+TO:>I*<".B))%W6A
M"$W1?^E$3'',7'!K(:159)Z]6^SYS'JCUBX3M7CF?,@ROT G$:"$1U\AZ4UY
M9")S7/X-<G(%G/(]/??)A#CMW(IV:7=FM"=V**T9@$O[8V>@S/8B>]A/DX]2
MKL=VY%FICEG9Y?<D#ZW)O.CC\50!TUF"Z2JPAJDX89Z-!+IR./%8 .X(1^26
M'M=->K1$GO]R)82<F\R_6 0IJU9R\T$E,3.:^05#DJ:>DF?D\<NS5! 92[U<
MR@>S:&292G0Z ^G[?8IHPH NS\!Q^':Z%("JG"2KI-Q965&^UL.;KN=3X$#]
M[#W/\A(D\"4!\&A$DA" !>J'8*0Q'QD!OJSH9;;"K^NR#?\LJ@.& 9O <6;,
MU7\4)\CV"0P75I<@'*+O43@(8ZA,SF @E27JAXA!EBA!1&46[<UB2Q;E\-AZ
M"QVZ&R,&I-A\2*G$4,U">(+V;.+2FUZD.H=*+VK'LYBT@2.@O9[CT905LY1E
MQZWSZV<7>4I9X[V$H?86#%LV/TYS>'0^12I,+-Z1VJ_,@_(@@/ED+YE)12I;
M8!ZBOTJ46!F:QZFG))WFJP3_N.<1%Z0XOUPG<XH@XKJ9*;)@EU(3 1I:-Y'B
MH0VJGDT#L&V" .S5$FKF*EWD<\F?,:J849;Z]#<WS(HIK("!-:)\P$I1$O09
M@+0"W:Z'/G2U"H,@4U%LNE/=/!,X  6RAEJE:2<FA%AJ/(5!E"E][)!51M.2
M2ETDKA\&78Z60%/SP)XE#^@N:*;/8-?BA4F9W<84#*+NZGQ0M*7Y6K!] UIS
MI2E(:YY2'*^ :$L2-HPBJD>SA&C4, =5CG3N[R756CN>L]M%,;,8=Q, L,F-
M%GY:BS*P)$<@W2SI$$DH,ZBMG<\>G]Q2$:-D9K;B&BFB*^DJE8HJW8BD:]Z<
M\XE:>--G4Z=.,P,!S$;)D3\M3-&E6!1$C?65XL[,<%P:"X.>#/_9@&%<=$L3
MY"4]: K1_'/0UPBL4-I*GD8OG454D*6B8 BLA1E[]-<-;=I$&A'LTYA?3)/W
M!714'@U9@JI-6PE7"SRV04O<DAQ,TW=IV&YJF['N \@:1@&M@_QGZ"7C.:LZ
MP5&7)(Q5K(E9UQ#K.TO/-_=*&M9,,?;0!Z+3T4PMLV4:91Q+AY;2AOG)4X+P
M_T-5@Z# [QSLL3ZE''X4 :!(/,<DU VQ'Q=3$@?ABKZE7@4 C]0EF_60!7ZA
MQ]3<6$DL2ED:_^V3I(1^ )NSZVM S<+48'"JN-8XR9>AS S)UI_4XF4#R699
MFKT1'CD$)[TBF,(QMCR?,A!X-;W-!J,,%T)1NG$B"OTY]^%4UR]-Y(4)!RQ]
M8 ;9.(HH%KT-V7"I9(&:H_G?G<SOLT; #U'NS5LI'2O5#LLA[Z>^RP<:9-8)
M(V=Z/1">Q'!@&0'<QSP#LQR$!82=)&>UW6:<R\0N%=,2JH,M$=+] ="]S#,Z
MP.-<QJB!FW<C1LRF M!,O4TT9N_/U$3[GL)N@"J]F9?8Q$Q@T-8PC7C3CKS(
MTO-6@&9]5L29QIR9W9/3_OZ8"0=\BIEG;KI%8F(S9?Q9DB'@P)(+ 0K9J=U$
MW9&W87H2KCCC(2J"(>I,LS3DJ3M&7KP612UJI"Y@%Z:%T;&/1Q;@F_5\??6X
M_$NS75R_!>!]A?/7G-ND%U[ FH^IN#//&W5H9U&75+="<TRGT]_,CH!EPYN7
MR&CH9QZ#B'2'/IY#:!3XXLQ_EVU-31%9NB7U72DABE\F;JX5;J8EI3+G LL2
M<-*%"@#6>*5+;,VRF\/B%4MPD2[GX8!UZ$'OF9BVX3UH]3 K;-;'D[IUYOI:
M0B?#B.W7]68B?]@*A\E*!;>Q94B71B^VAW&\WF+KAS%-4$WK><@Q1F,/=H\X
M=%>P(%>*:\RY.9?7"G?]9EN,:+:#Z4L/RO@;V/6C[7?]+![V'EJY>Q0F40.
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MR]'K^R"WP-UX8(7.&'[UDKY_]/]02P,$%     @ 5G255G2SZ&EF @  ;@<
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MWG<NT3<YLI@ND8;&25"+?"Z"JHC,!H,9L:J-+C,%20-[8H /7&\$7@S[OZ(
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MB'8*?&V0&UL1Y8_KV%3!K;$K^Y#K905<'<3)CFRB4:1Y:<8S"6T)8B*YVA>
M9Z;0)9;JP\+\?NV_BJB#S3:V7(O;HJ8M[(ZY]<*[Z'\XQTJV6,N4$Z38';"M
MUH(V9Q#(7B_]""1 96OLJ*V57J/USB1:V,3D%E(4]4"Z_)@2I'':\)$)^N#.
MWB,FVMQ<FDW-:*XQ*E!K(BR G43_0&?:Q"L,BS=-,E-7%/&FR4:W+,(WF(^<
MSAJR)KL>:)Y55TR6#C:QB<388QOJEI"OAH61AR:)&=C<K!6YK_(3MD;C6QL
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MT_*KF7:?8P(V=\U3Y<^_.UMPHM2N!@G(YB$AX9;52CB0XXI\J6&4F\85M(R
MG[3Z6[ E@?-5#=59Y*,MVGAG[;S$X\*UI8*;+.80+ZI6635'PZ-E"+4W[J6
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MDU*4U[46IW6*<@CY%!%+4=O.8C('KBJ@X)@A6TET%22F50Y19:LJH]M@@$[
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MK/,-_QD7D_B7_P=02P$"% ,4    " !6=)56^NQ\YI<@  "5$0$ $0
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H97-T<FEC=&5D<W1O8VLN:'1M4$L%!@     &  8 G $  -&B      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
